Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3525LS3W
Performance in the last:
Follow this Portfolio
1D -0.2 %
1W 2.0 %
2W 0.4 %
1M -0.6 %
3M 1.9 %
6M -40.5 %
9M -37.3 %
1Y -39.1 %
Alpha
-52.7%
Beta
0.55
sharpe-R
-0.78
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:53
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -50.18%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 25.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
PODD Insulet Corporation Equity Buy 9.83% 15.22%
ESPR Esperion Therapeutics, Inc. Equity Buy 8.73% -2.73%
NVCR NovoCure Limited Equity Buy 7.77% -0.17%
MYGN Myriad Genetics, Inc. Equity Buy 7.82% 6.04%
LMAT LeMaitre Vascular, Inc. Equity Sell -3.72% 0.25%
AVXL Anavex Life Sciences Corp. Equity Sell -3.47% 7.14%
CERS Cerus Corporation Equity Sell -3.73% 6.64%
The percentage of cash held in the portfolio is: 76.77%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.83% 15.22%
ESPR Esperion Therapeutics, Inc. Buy 8.73% -2.73%
NVCR NovoCure Limited Buy 7.77% -0.17%
MYGN Myriad Genetics, Inc. Buy 7.82% 6.04%
LMAT LeMaitre Vascular, Inc. Sell -3.72% 0.25%
AVXL Anavex Life Sciences Corp. Sell -3.47% 7.14%
CERS Cerus Corporation Sell -3.73% 6.64%
The percentage of cash held in the portfolio is: 76.77%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 0.59%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.82% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 8.69% -3.83%
NVCR NovoCure Limited Buy 7.79% -0.5%
MYGN Myriad Genetics, Inc. Buy 7.68% 3.45%
STAA STAAR Surgical Company Sell -3.7% 3.06%
LMAT LeMaitre Vascular, Inc. Sell -3.8% -1.08%
AVXL Anavex Life Sciences Corp. Sell -3.64% 3.06%
CERS Cerus Corporation Sell -3.93% 2.37%
The percentage of cash held in the portfolio is: 81.07%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -2.28%
AADI Sell All 7.43%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 6.31% 1.14%
PODD Insulet Corporation Buy 9.82% 12.73%
MGNX MacroGenics, Inc. Buy 9.43% 2.85%
ESPR Esperion Therapeutics, Inc. Buy 8.77% -4.37%
TVTX Travere Therapeutics, Inc. Buy 9.26% 31.25%
NVCR NovoCure Limited Buy 7.63% -3.99%
MYGN Myriad Genetics, Inc. Buy 7.37% -2.15%
STAA STAAR Surgical Company Sell -3.58% 7.41%
LMAT LeMaitre Vascular, Inc. Sell -3.77% 0.97%
AVXL Anavex Life Sciences Corp. Sell -3.38% 11.39%
CERS Cerus Corporation Sell -3.95% 3.32%
The percentage of cash held in the portfolio is: 56.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 8.41%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 6.13% 3.11%
AADI Aadi Bioscience, Inc. Buy 6.59% 5.14%
PODD Insulet Corporation Buy 9.75% 11.4%
MGNX MacroGenics, Inc. Buy 9.5% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 8.76% -4.92%
TVTX Travere Therapeutics, Inc. Buy 9.04% 27.5%
NVCR NovoCure Limited Buy 7.62% -4.54%
MYGN Myriad Genetics, Inc. Buy 7.38% -2.56%
STAA STAAR Surgical Company Sell -3.64% 6.36%
LMAT LeMaitre Vascular, Inc. Sell -3.73% 2.57%
AVXL Anavex Life Sciences Corp. Sell -3.34% 12.76%
CERS Cerus Corporation Sell -3.99% 2.84%
The percentage of cash held in the portfolio is: 49.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.22%
APLS Sell All -3.75%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.84% -1.69%
AGEN Agenus Inc. Buy 5.93% -0.18%
AADI Aadi Bioscience, Inc. Buy 6.37% 1.71%
PODD Insulet Corporation Buy 9.69% 10.8%
MGNX MacroGenics, Inc. Buy 9.34% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 8.7% -5.46%
TVTX Travere Therapeutics, Inc. Buy 9.47% 33.75%
NVCR NovoCure Limited Buy 7.47% -6.37%
MYGN Myriad Genetics, Inc. Buy 7.58% 0.26%
STAA STAAR Surgical Company Sell -3.62% 6.89%
LMAT LeMaitre Vascular, Inc. Sell -3.71% 3.03%
AVXL Anavex Life Sciences Corp. Sell -3.26% 14.88%
VREX Varex Imaging Corporation Sell -3.98% 2.99%
CERS Cerus Corporation Sell -3.98% 2.84%
The percentage of cash held in the portfolio is: 48.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All 0.85%
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.93% 0.21%
CARA Cara Therapeutics, Inc. Buy 5.35% -9.62%
AGEN Agenus Inc. Buy 5.55% -6.22%
AADI Aadi Bioscience, Inc. Buy 6.45% 3.43%
PODD Insulet Corporation Buy 9.33% 7.2%
MGNX MacroGenics, Inc. Buy 9.01% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 8.51% -7.1%
TVTX Travere Therapeutics, Inc. Buy 9.45% 33.96%
NVCR NovoCure Limited Buy 7.3% -7.98%
MYGN Myriad Genetics, Inc. Buy 7.58% 0.63%
CDMO Avid Bioservices, Inc. Sell -3.28% 15.41%
STAA STAAR Surgical Company Sell -3.59% 7.17%
LMAT LeMaitre Vascular, Inc. Sell -3.7% 2.83%
AVXL Anavex Life Sciences Corp. Sell -3.34% 12.41%
VREX Varex Imaging Corporation Sell -3.57% 12.56%
CERS Cerus Corporation Sell -3.91% 4.27%
The percentage of cash held in the portfolio is: 46.93%
New Assets Added
None
Assets Removed
Asset Action Perf %
BGNE Buy All -0.8%
PACB Buy All -22.96%
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 6.22% 3%
CARA Cara Therapeutics, Inc. Buy 5.67% -6.12%
AGEN Agenus Inc. Buy 5.47% -9.51%
AADI Aadi Bioscience, Inc. Buy 6.66% 4.57%
PODD Insulet Corporation Buy 9.34% 5.05%
MGNX MacroGenics, Inc. Buy 8.67% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 8.44% -9.84%
TVTX Travere Therapeutics, Inc. Buy 8.24% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 7.89% -3.01%
NVCR NovoCure Limited Buy 7.58% -6.48%
MYGN Myriad Genetics, Inc. Buy 7.69% 0%
CDMO Avid Bioservices, Inc. Sell -3.3% 16.54%
STAA STAAR Surgical Company Sell -3.8% 3.86%
LMAT LeMaitre Vascular, Inc. Sell -3.85% 1.1%
AVXL Anavex Life Sciences Corp. Sell -3.41% 12.41%
PACB Pacific Biosciences of California, Inc. Sell -4.55% -17.04%
BGNE BeiGene, Ltd. Sell -3.28% 0.24%
VREX Varex Imaging Corporation Sell -4.11% 1.28%
CERS Cerus Corporation Sell -3.99% 4.27%
The percentage of cash held in the portfolio is: 48.43%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.91% -1.42%
ORGO Organogenesis Holdings Inc. Buy 5.6% -6.71%
CARA Cara Therapeutics, Inc. Buy 5.62% -6.41%
AGEN Agenus Inc. Buy 5.48% -8.59%
AADI Aadi Bioscience, Inc. Buy 6.51% 2.86%
PODD Insulet Corporation Buy 9.34% 5.72%
MGNX MacroGenics, Inc. Buy 8.95% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 8.74% -6.01%
TVTX Travere Therapeutics, Inc. Buy 7.4% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 8.08% 0%
NVCR NovoCure Limited Buy 8.05% 0%
CDMO Avid Bioservices, Inc. Sell -3.34% 14.93%
STAA STAAR Surgical Company Sell -3.78% 3.61%
LMAT LeMaitre Vascular, Inc. Sell -3.82% 1.07%
AVXL Anavex Life Sciences Corp. Sell -3.65% 5.44%
PACB Pacific Biosciences of California, Inc. Sell -4.01% -3.7%
BGNE BeiGene, Ltd. Sell -3.26% 0.1%
VREX Varex Imaging Corporation Sell -4.24% -2.31%
CERS Cerus Corporation Sell -4.08% 1.42%
The percentage of cash held in the portfolio is: 50.51%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.68% -5.21%
ORGO Organogenesis Holdings Inc. Buy 5.71% -4.59%
CARA Cara Therapeutics, Inc. Buy 5.62% -6.12%
AGEN Agenus Inc. Buy 5.31% -11.33%
AADI Aadi Bioscience, Inc. Buy 6.49% 2.86%
PODD Insulet Corporation Buy 9.17% 3.96%
MGNX MacroGenics, Inc. Buy 8.78% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 9.23% -0.55%
TVTX Travere Therapeutics, Inc. Buy 7.48% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 8.07% 0%
CDMO Avid Bioservices, Inc. Sell -3.42% 12.67%
STAA STAAR Surgical Company Sell -3.81% 2.72%
LMAT LeMaitre Vascular, Inc. Sell -3.83% 0.61%
AVXL Anavex Life Sciences Corp. Sell -3.69% 4.42%
PACB Pacific Biosciences of California, Inc. Sell -3.77% 2.22%
BGNE BeiGene, Ltd. Sell -3.21% 1.63%
VREX Varex Imaging Corporation Sell -4.13% 0%
CERS Cerus Corporation Sell -4.13% 0%
The percentage of cash held in the portfolio is: 58.46%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.85% -2.65%
ORGO Organogenesis Holdings Inc. Buy 5.79% -3.53%
CARA Cara Therapeutics, Inc. Buy 5.8% -3.5%
AGEN Agenus Inc. Buy 5.43% -9.51%
CERS Cerus Corporation Buy 5.82% -7.98%
AADI Aadi Bioscience, Inc. Buy 6.29% -0.57%
PODD Insulet Corporation Buy 8.94% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.92% -10.38%
MGNX MacroGenics, Inc. Buy 8.7% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 9.31% 0%
TVTX Travere Therapeutics, Inc. Buy 7.16% 0%
CDMO Avid Bioservices, Inc. Sell -3.62% 8.03%
STAA STAAR Surgical Company Sell -3.92% 0.15%
LMAT LeMaitre Vascular, Inc. Sell -3.8% 1.75%
AVXL Anavex Life Sciences Corp. Sell -3.59% 7.14%
PACB Pacific Biosciences of California, Inc. Sell -3.84% 0.74%
BGNE BeiGene, Ltd. Sell -3.21% 1.84%
The percentage of cash held in the portfolio is: 44.96%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 5.68% -2.4%
ORGO Organogenesis Holdings Inc. Buy 5.92% 1.77%
CARA Cara Therapeutics, Inc. Buy 6.11% 4.96%
AGEN Agenus Inc. Buy 5.48% -5.85%
CERS Cerus Corporation Buy 5.82% -5.04%
AADI Aadi Bioscience, Inc. Buy 6.34% 3.43%
NEOG Neogen Corporation Buy 6.92% 0.35%
PODD Insulet Corporation Buy 8.5% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.47% -1.15%
MGNX MacroGenics, Inc. Buy 9.02% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.02% 0%
CDMO Avid Bioservices, Inc. Sell -3.8% 0.38%
STAA STAAR Surgical Company Sell -3.89% -2.22%
PINC Premier, Inc. Sell -3.92% -2.93%
LMAT LeMaitre Vascular, Inc. Sell -3.8% -1.4%
AVXL Anavex Life Sciences Corp. Sell -3.84% -2.38%
VERU Veru Inc. Sell -3.79% -1.23%
PACB Pacific Biosciences of California, Inc. Sell -3.8% -1.48%
BGNE BeiGene, Ltd. Sell -3.17% 0%
The percentage of cash held in the portfolio is: 47.08%
New Assets Added
  • BGNE
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 5.58% -4.2%
ORGO Organogenesis Holdings Inc. Buy 6.03% 3.53%
CARA Cara Therapeutics, Inc. Buy 6.04% 3.79%
AGEN Agenus Inc. Buy 5.44% -6.58%
CERS Cerus Corporation Buy 5.78% -5.88%
AADI Aadi Bioscience, Inc. Buy 5.89% -4%
NEOG Neogen Corporation Buy 6.75% -2.15%
PODD Insulet Corporation Buy 8.57% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.57% 0%
CDMO Avid Bioservices, Inc. Sell -3.68% 3.4%
STAA STAAR Surgical Company Sell -3.75% 1.42%
PINC Premier, Inc. Sell -3.82% -0.3%
LMAT LeMaitre Vascular, Inc. Sell -3.75% 0%
AVXL Anavex Life Sciences Corp. Sell -3.75% 0%
VERU Veru Inc. Sell -3.75% 0%
PACB Pacific Biosciences of California, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • LMAT
  • AVXL
  • VERU
  • PACB
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.62% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 5.72% -0.64%
ORGO Organogenesis Holdings Inc. Buy 5.98% 3.89%
CARA Cara Therapeutics, Inc. Buy 6.02% 4.66%
AGEN Agenus Inc. Buy 5.92% 2.93%
CERS Cerus Corporation Buy 5.91% -2.52%
AADI Aadi Bioscience, Inc. Buy 5.82% -4%
NEOG Neogen Corporation Buy 6.82% 0%
CDMO Avid Bioservices, Inc. Sell -3.66% 2.74%
STAA STAAR Surgical Company Sell -3.76% 0%
PINC Premier, Inc. Sell -3.76% 0%
The percentage of cash held in the portfolio is: 63.38%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.64% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 5.69% -0.05%
ORGO Organogenesis Holdings Inc. Buy 6.09% 7.07%
CARA Cara Therapeutics, Inc. Buy 6.14% 7.87%
AGEN Agenus Inc. Buy 6.11% 7.31%
CERS Cerus Corporation Buy 6% 0%
AADI Aadi Bioscience, Inc. Buy 6% 0%
CDMO Avid Bioservices, Inc. Sell -3.65% 2.08%
The percentage of cash held in the portfolio is: 61.99%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.71% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% 0.64%
ORGO Organogenesis Holdings Inc. Buy 5.93% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.81% 1.46%
AGEN Agenus Inc. Buy 6.07% 6.03%
CDMO Avid Bioservices, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 74.46%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.51% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 5.69% -1.79%
ORGO Organogenesis Holdings Inc. Buy 5.63% -2.83%
CARA Cara Therapeutics, Inc. Buy 5.8% 0%
AGEN Agenus Inc. Buy 5.8% 0%
The percentage of cash held in the portfolio is: 71.57%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 5.76% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 5.76% 0%
ORGO Organogenesis Holdings Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 82.71%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-21 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Buy All 24.66%
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.69% 25.56%
The percentage of cash held in the portfolio is: 102.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
EGRX Buy All 4.43%
CYH Sell All -1.57%
Assets Rebalanced
None
2024-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 7% -2.95%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.72% 24.66%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.16% 12.45%
The percentage of cash held in the portfolio is: 98.88%
New Assets Added
None
Assets Removed
Asset Action Perf %
CPRX Buy All -6.15%
PODD Buy All -2.48%
NKTR Buy All 10.37%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.63% -7.66%
PODD Insulet Corporation Sell -3.6% 2.34%
NKTR Nektar Therapeutics Sell -3.22% 12.59%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.51% 30.04%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.22% 10.34%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.75% 5.86%
The percentage of cash held in the portfolio is: 109.67%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Buy All -20.7%
RMD Sell All 1.39%
RCM Sell All 7.14%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 6.08% 7.06%
CYH Community Health Systems, Inc. Buy 6.68% -5.3%
RMD ResMed Inc. Buy 14.05% 3.67%
PODD Insulet Corporation Sell -3.54% 2.25%
NKTR Nektar Therapeutics Sell -3.13% 13.33%
INGN Inogen, Inc. Sell -3.14% 10.89%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.41% 31.84%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.25% 8.02%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.52% 10.15%
The percentage of cash held in the portfolio is: 92.18%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All -5.42%
FATE Sell All 7.71%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 4.03% -1.06%
FATE Fate Therapeutics, Inc. Buy 4.85% 19.02%
RCM R1 RCM Inc. Buy 6.1% 7.83%
CYH Community Health Systems, Inc. Buy 6.88% -1.96%
RMD ResMed Inc. Buy 14.5% 7.5%
PODD Insulet Corporation Sell -3.63% -0.76%
NKTR Nektar Therapeutics Sell -3.2% 11.11%
INGN Inogen, Inc. Sell -3.27% 6.97%
LXRX Lexicon Pharmaceuticals, Inc. Sell -2.68% 23.77%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.41% 2.95%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.73% 4.47%
The percentage of cash held in the portfolio is: 83.55%
New Assets Added
None
Assets Removed
Asset Action Perf %
RARE Buy All -17.98%
HQY Sell All -11.82%
SAVA Sell All 95.11%
SAGE Sell All -12.65%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 4.23% 1.06%
FATE Fate Therapeutics, Inc. Buy 5.25% 25.45%
RCM R1 RCM Inc. Buy 6.3% 8.44%
CYH Community Health Systems, Inc. Buy 7.1% -1.57%
HQY HealthEquity, Inc. Buy 6.94% -3.84%
SAVA Cassava Sciences, Inc. Buy 11.36% 57.44%
SAGE Sage Therapeutics, Inc. Buy 6.41% -11.19%
HCSG Healthcare Services Group, Inc. Buy 2.94% -3.72%
RMD ResMed Inc. Buy 14.3% 3.13%
PODD Insulet Corporation Sell -3.74% -1.17%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.82% -3.2%
NKTR Nektar Therapeutics Sell -3.48% 5.93%
INGN Inogen, Inc. Sell -3.58% 0.87%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.27% 9.42%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.64% -0.84%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.94% 1.8%
The percentage of cash held in the portfolio is: 60.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGRY Sell All 18.28%
RGNX Sell All 4.72%
AVNS Sell All 12.13%
CUTR Sell All -12.16%
ANGO Sell All 27.08%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGRY Surgery Partners, Inc. Buy 7.03% 18.83%
RGNX REGENXBIO Inc. Buy 6.63% 12.12%
AVNS Avanos Medical, Inc. Buy 6.68% 12.94%
CUTR Cutera, Inc. Buy 5.6% -5.41%
ANGO AngioDynamics, Inc. Buy 8.5% 27.9%
BKD Brookdale Senior Living Inc. Buy 4.25% 2.25%
FATE Fate Therapeutics, Inc. Buy 5.69% 37.02%
RCM R1 RCM Inc. Buy 5.7% -1.15%
CYH Community Health Systems, Inc. Buy 7.4% 3.34%
HQY HealthEquity, Inc. Buy 6.94% -3.09%
SAVA Cassava Sciences, Inc. Buy 10.66% 48.93%
SAGE Sage Therapeutics, Inc. Buy 7.13% -0.36%
HCSG Healthcare Services Group, Inc. Buy 3% -1.12%
RMD ResMed Inc. Buy 14.1% 2.5%
PODD Insulet Corporation Sell -3.66% 0.31%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.87% -5.24%
NKTR Nektar Therapeutics Sell -3.65% 0.74%
INGN Inogen, Inc. Sell -3.61% -0.76%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.62% -0.9%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.64% -1.69%
CPRX Catalyst Pharmaceuticals, Inc. Sell -3.98% 0%
The percentage of cash held in the portfolio is: 26.69%
New Assets Added
  • CPRX
Assets Removed
Asset Action Perf %
SMTI Buy All -6.87%
OPK Sell All 7.58%
PDSB Sell All 1.14%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.78% 8.33%
PDSB PDS Biotechnology Corporation Buy 5.24% -1.7%
SGRY Surgery Partners, Inc. Buy 7.44% 22.27%
RGNX REGENXBIO Inc. Buy 6.84% 12.43%
AVNS Avanos Medical, Inc. Buy 6.59% 8.4%
CUTR Cutera, Inc. Buy 5.92% -2.7%
ANGO AngioDynamics, Inc. Buy 8.72% 27.73%
BKD Brookdale Senior Living Inc. Buy 4.42% 3.44%
FATE Fate Therapeutics, Inc. Buy 5.63% 31.88%
RCM R1 RCM Inc. Buy 5.87% -1%
CYH Community Health Systems, Inc. Buy 7.46% 1.38%
HQY HealthEquity, Inc. Buy 7.13% -3.16%
SAVA Cassava Sciences, Inc. Buy 8.67% 17.76%
SAGE Sage Therapeutics, Inc. Buy 7.23% -1.73%
HCSG Healthcare Services Group, Inc. Buy 3.11% -0.43%
RMD ResMed Inc. Buy 14.14% 0%
PODD Insulet Corporation Sell -3.75% 0.6%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.94% -4.51%
NKTR Nektar Therapeutics Sell -3.89% -2.96%
SMTI Sanara MedTech Inc. Sell -3.68% 0%
INGN Inogen, Inc. Sell -3.68% 0%
LXRX Lexicon Pharmaceuticals, Inc. Sell -3.68% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -3.68% 0%
The percentage of cash held in the portfolio is: 16.14%
New Assets Added
  • SMTI
  • INGN
  • LXRX
  • EGRX
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.68% 8.33%
PDSB PDS Biotechnology Corporation Buy 5.69% 8.52%
SGRY Surgery Partners, Inc. Buy 7.28% 21.76%
RGNX REGENXBIO Inc. Buy 6.75% 12.9%
AVNS Avanos Medical, Inc. Buy 6.46% 8.03%
CUTR Cutera, Inc. Buy 5.65% -5.41%
ANGO AngioDynamics, Inc. Buy 8.39% 24.96%
BKD Brookdale Senior Living Inc. Buy 4.38% 4.37%
FATE Fate Therapeutics, Inc. Buy 5.84% 39.07%
RCM R1 RCM Inc. Buy 5.67% -2.61%
CLDX Celldex Therapeutics, Inc. Buy 7.29% -4.26%
SMTI Sanara MedTech Inc. Buy 6.84% -5.45%
CYH Community Health Systems, Inc. Buy 7.36% 1.77%
HQY HealthEquity, Inc. Buy 7.11% -1.69%
SAVA Cassava Sciences, Inc. Buy 8.74% 20.78%
SAGE Sage Therapeutics, Inc. Buy 7.11% -1.64%
HCSG Healthcare Services Group, Inc. Buy 3.07% 0%
PODD Insulet Corporation Sell -3.65% 1.61%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.92% -5.75%
NKTR Nektar Therapeutics Sell -3.74% -0.74%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
RMD Buy All -5.84%
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.82% 12.12%
PDSB PDS Biotechnology Corporation Buy 5.71% 10.23%
SGRY Surgery Partners, Inc. Buy 7.4% 25.32%
RGNX REGENXBIO Inc. Buy 6.66% 12.75%
AVNS Avanos Medical, Inc. Buy 6.46% 9.25%
CUTR Cutera, Inc. Buy 6.07% 2.7%
ANGO AngioDynamics, Inc. Buy 8.28% 24.8%
BKD Brookdale Senior Living Inc. Buy 4.39% 5.69%
FATE Fate Therapeutics, Inc. Buy 5.8% 39.85%
RCM R1 RCM Inc. Buy 5.75% -0.19%
PTGX Protagonist Therapeutics, Inc. Buy 7.24% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 7.65% 1.6%
SMTI Sanara MedTech Inc. Buy 7.15% 0%
CYH Community Health Systems, Inc. Buy 7.15% 0%
HQY HealthEquity, Inc. Buy 7.15% 0%
SAVA Cassava Sciences, Inc. Buy 7.15% 0%
SAGE Sage Therapeutics, Inc. Buy 7.15% 0%
PODD Insulet Corporation Sell -3.64% 0.85%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.85% -4.86%
NKTR Nektar Therapeutics Sell -3.75% -2.22%
RMD ResMed Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RMD
  • SMTI
  • CYH
  • HQY
  • SAVA
  • SAGE
Assets Removed
Asset Action Perf %
WAT Buy All -5.03%
ATRC Sell All -12.65%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.62% 7.58%
PDSB PDS Biotechnology Corporation Buy 5.84% 11.93%
SGRY Surgery Partners, Inc. Buy 7.16% 20.35%
RGNX REGENXBIO Inc. Buy 6.73% 13.22%
AVNS Avanos Medical, Inc. Buy 6.44% 8.22%
CUTR Cutera, Inc. Buy 5.63% -5.41%
ANGO AngioDynamics, Inc. Buy 8.18% 22.51%
BKD Brookdale Senior Living Inc. Buy 4.32% 3.44%
FATE Fate Therapeutics, Inc. Buy 5.8% 38.82%
ATRC AtriCure, Inc. Buy 6.11% -7%
RCM R1 RCM Inc. Buy 5.75% -0.84%
PTGX Protagonist Therapeutics, Inc. Buy 7.53% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 7.58% 0%
PODD Insulet Corporation Sell -3.61% 2.09%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.89% -5.33%
NKTR Nektar Therapeutics Sell -3.75% -1.48%
WAT Waters Corporation Sell -3.74% -2.5%
The percentage of cash held in the portfolio is: 32.32%
New Assets Added
  • CLDX
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.68% 7.58%
PDSB PDS Biotechnology Corporation Buy 5.64% 6.96%
SGRY Surgery Partners, Inc. Buy 6.98% 16.16%
RGNX REGENXBIO Inc. Buy 6.45% 7.32%
AVNS Avanos Medical, Inc. Buy 6.41% 6.7%
CUTR Cutera, Inc. Buy 5.85% -2.7%
ANGO AngioDynamics, Inc. Buy 8.07% 19.58%
BKD Brookdale Senior Living Inc. Buy 4.38% 3.7%
FATE Fate Therapeutics, Inc. Buy 5.62% 33.16%
ATRC AtriCure, Inc. Buy 6.3% -5.18%
RCM R1 RCM Inc. Buy 5.91% 0.92%
PTGX Protagonist Therapeutics, Inc. Buy 7.66% 0%
PODD Insulet Corporation Sell -3.72% 0.3%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.93% -5.45%
NKTR Nektar Therapeutics Sell -3.9% -4.44%
WAT Waters Corporation Sell -3.72% -0.86%
The percentage of cash held in the portfolio is: 40.32%
New Assets Added
  • PTGX
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 5.87% 10.61%
PDSB PDS Biotechnology Corporation Buy 5.88% 10.8%
SGRY Surgery Partners, Inc. Buy 6.67% 10.29%
RGNX REGENXBIO Inc. Buy 6.08% 0.47%
AVNS Avanos Medical, Inc. Buy 6.43% 6.28%
CUTR Cutera, Inc. Buy 6.66% 10.14%
ANGO AngioDynamics, Inc. Buy 7.9% 16.31%
BKD Brookdale Senior Living Inc. Buy 4.37% 2.78%
FATE Fate Therapeutics, Inc. Buy 4.98% 17.22%
ATRC AtriCure, Inc. Buy 6.29% -5.85%
RCM R1 RCM Inc. Buy 6.02% 2.15%
PODD Insulet Corporation Sell -3.74% 0.37%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.9% -3.93%
NKTR Nektar Therapeutics Sell -4.06% -8.15%
WAT Waters Corporation Sell -3.77% -1.49%
The percentage of cash held in the portfolio is: 48.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Sell All 13.4%
RYTM Sell All 16.66%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 6.01% 9.54%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.12% 16.17%
OPK OPKO Health, Inc. Buy 6.01% 12.88%
PDSB PDS Biotechnology Corporation Buy 5.85% 9.94%
SGRY Surgery Partners, Inc. Buy 6.89% 13.7%
RGNX REGENXBIO Inc. Buy 6% -1.02%
AVNS Avanos Medical, Inc. Buy 6.29% 3.82%
CUTR Cutera, Inc. Buy 6.51% 7.43%
ANGO AngioDynamics, Inc. Buy 7.98% 17.13%
BKD Brookdale Senior Living Inc. Buy 4.31% 1.19%
FATE Fate Therapeutics, Inc. Buy 4.67% 9.77%
ATRC AtriCure, Inc. Buy 6.4% -4.47%
RCM R1 RCM Inc. Buy 6.03% 2%
PODD Insulet Corporation Sell -3.76% -0.04%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.74% 0.54%
NKTR Nektar Therapeutics Sell -3.87% -2.96%
WAT Waters Corporation Sell -3.72% 0%
The percentage of cash held in the portfolio is: 36.04%
New Assets Added
  • WAT
Assets Removed
Asset Action Perf %
TDOC Sell All -2.99%
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 5.99% 9.54%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.06% 15.44%
ALT Altimmune, Inc. Buy 5.1% -12.43%
OPK OPKO Health, Inc. Buy 6.11% 15.15%
PDSB PDS Biotechnology Corporation Buy 5.81% 9.66%
SGRY Surgery Partners, Inc. Buy 6.88% 13.89%
RGNX REGENXBIO Inc. Buy 6.11% 1.1%
TDOC Teladoc Health, Inc. Buy 6% -0.64%
AVNS Avanos Medical, Inc. Buy 6.4% 5.95%
CUTR Cutera, Inc. Buy 6.33% 4.73%
ANGO AngioDynamics, Inc. Buy 7.69% 13.38%
BKD Brookdale Senior Living Inc. Buy 4.31% 1.59%
FATE Fate Therapeutics, Inc. Buy 4.7% 10.8%
ATRC AtriCure, Inc. Buy 6.51% -2.49%
RCM R1 RCM Inc. Buy 5.8% -1.46%
PODD Insulet Corporation Sell -3.75% 0%
RARE Ultragenyx Pharmaceutical Inc. Sell -3.75% 0%
NKTR Nektar Therapeutics Sell -3.75% 0%
The percentage of cash held in the portfolio is: 21.44%
New Assets Added
  • PODD
  • RARE
  • NKTR
Assets Removed
Asset Action Perf %
FGEN Buy All -0.97%
CYH Sell All 17.81%
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.15% 23.12%
VRDN Viridian Therapeutics, Inc. Buy 6.08% 15.37%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.18% 22.05%
ALT Altimmune, Inc. Buy 5.62% 0.13%
OPK OPKO Health, Inc. Buy 5.5% 7.58%
PDSB PDS Biotechnology Corporation Buy 5.82% 13.92%
SGRY Surgery Partners, Inc. Buy 6.73% 15.66%
RGNX REGENXBIO Inc. Buy 6.08% 4.48%
TDOC Teladoc Health, Inc. Buy 6.23% 7.04%
AVNS Avanos Medical, Inc. Buy 6.22% 6.89%
CUTR Cutera, Inc. Buy 6.57% 12.84%
ANGO AngioDynamics, Inc. Buy 7.89% 20.72%
WST West Pharmaceutical Services, Inc. Buy 5.71% -1.88%
BKD Brookdale Senior Living Inc. Buy 4.18% 2.25%
FATE Fate Therapeutics, Inc. Buy 4.69% 14.65%
ATRC AtriCure, Inc. Buy 6.37% -0.91%
RCM R1 RCM Inc. Buy 5.67% 0%
FGEN FibroGen, Inc. Sell -3.69% -3.88%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 6.17% 25%
VRDN Viridian Therapeutics, Inc. Buy 6.29% 20.89%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.32% 26.29%
BHVN Biohaven Ltd. Buy 5.84% 4.86%
ALT Altimmune, Inc. Buy 6.01% 8.29%
OPK OPKO Health, Inc. Buy 5.51% 9.09%
PDSB PDS Biotechnology Corporation Buy 5.94% 17.76%
SGRY Surgery Partners, Inc. Buy 6.27% 8.92%
RGNX REGENXBIO Inc. Buy 6.14% 6.69%
TDOC Teladoc Health, Inc. Buy 6.2% 7.68%
AVNS Avanos Medical, Inc. Buy 6% 4.2%
CUTR Cutera, Inc. Buy 6.45% 12.16%
ANGO AngioDynamics, Inc. Buy 7.92% 22.51%
WST West Pharmaceutical Services, Inc. Buy 5.68% -1.26%
BKD Brookdale Senior Living Inc. Buy 4.08% 0.93%
FATE Fate Therapeutics, Inc. Buy 4.73% 16.97%
ATRC AtriCure, Inc. Buy 6.36% 0%
FGEN FibroGen, Inc. Sell -3.89% -10.68%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ATRC
Assets Removed
Asset Action Perf %
RARE Sell All 13.6%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
RARE Ultragenyx Pharmaceutical Inc. Buy 6.71% 11.57%
CYH Community Health Systems, Inc. Buy 6.36% 21.88%
VRDN Viridian Therapeutics, Inc. Buy 6.11% 11.2%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.43% 21.63%
BHVN Biohaven Ltd. Buy 6.25% 6.27%
ALT Altimmune, Inc. Buy 6.19% 5.61%
OPK OPKO Health, Inc. Buy 5.78% 8.33%
PDSB PDS Biotechnology Corporation Buy 6.4% 20.03%
SGRY Surgery Partners, Inc. Buy 6.12% 0.74%
RGNX REGENXBIO Inc. Buy 6.15% 1.26%
TDOC Teladoc Health, Inc. Buy 6.01% -1.17%
AVNS Avanos Medical, Inc. Buy 6.01% -1.18%
CUTR Cutera, Inc. Buy 6.32% 4.05%
ANGO AngioDynamics, Inc. Buy 6.6% -3.26%
WST West Pharmaceutical Services, Inc. Buy 5.84% -3.96%
BKD Brookdale Senior Living Inc. Buy 4.27% 0%
FATE Fate Therapeutics, Inc. Buy 4.27% 0%
FGEN FibroGen, Inc. Sell -3.82% -2.91%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BKD
  • FATE
Assets Removed
Asset Action Perf %
APLS Buy All -10.22%
ACAD Sell All 13.54%
EGRX Sell All 33.26%
Assets Rebalanced
None
2024-07-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.46% 11.9%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.24% 34.37%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.86% 13.27%
CYH Community Health Systems, Inc. Buy 6.24% 18.75%
VRDN Viridian Therapeutics, Inc. Buy 5.83% 5.15%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.24% 17.23%
BHVN Biohaven Ltd. Buy 6.24% 5.28%
ALT Altimmune, Inc. Buy 6.24% 5.61%
OPK OPKO Health, Inc. Buy 5.62% 4.55%
PDSB PDS Biotechnology Corporation Buy 6.24% 16.19%
SGRY Surgery Partners, Inc. Buy 6.44% 5.17%
RGNX REGENXBIO Inc. Buy 6.16% 0.47%
TDOC Teladoc Health, Inc. Buy 6.14% 0.21%
AVNS Avanos Medical, Inc. Buy 6.1% -0.47%
CUTR Cutera, Inc. Buy 6.09% -0.68%
ANGO AngioDynamics, Inc. Buy 6.74% -2.12%
WST West Pharmaceutical Services, Inc. Buy 5.94% -3.1%
FGEN FibroGen, Inc. Sell -3.78% -0.97%
APLS Apellis Pharmaceuticals, Inc. Sell -4.37% -8.93%
The percentage of cash held in the portfolio is: 2.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGMO Buy All -25%
CDNA Buy All -10.41%
Assets Rebalanced
Asset Action Weight
VRDN Sell -0.97%
OPK Sell -1.34%
BHVN Sell -0.77%
ALT Sell -0.79%
RYTM Sell -1.33%
PDSB Sell -1.49%
EGRX Sell -1.51%
CYH Sell -1.55%
ANGO Buy 0.25%
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.52% 11.15%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.89% 34.6%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.78% 10.14%
CYH Community Health Systems, Inc. Buy 7.73% 15.94%
VRDN Viridian Therapeutics, Inc. Buy 6.44% -1.97%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.17% 9.21%
PDSB PDS Biotechnology Corporation Buy 7.46% 10.23%
BHVN Biohaven Ltd. Buy 7.1% 4.89%
ALT Altimmune, Inc. Buy 6.95% 2.67%
OPK OPKO Health, Inc. Buy 7.02% 3.79%
WST West Pharmaceutical Services, Inc. Buy 6.23% 0%
ANGO AngioDynamics, Inc. Buy 6.23% 0%
TDOC Teladoc Health, Inc. Buy 6.23% 0%
SGRY Surgery Partners, Inc. Buy 6.23% 0%
AVNS Avanos Medical, Inc. Buy 6.23% 0%
CUTR Cutera, Inc. Buy 6.23% 0%
RGNX REGENXBIO Inc. Buy 6.23% 0%
FGEN FibroGen, Inc. Sell -3.61% 4.95%
SGMO Sangamo Therapeutics, Inc. Sell -4.83% -22.22%
APLS Apellis Pharmaceuticals, Inc. Sell -4.37% -7.16%
CDNA CareDx, Inc Sell -3.83% -9.44%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
  • ANGO
  • TDOC
  • SGRY
  • AVNS
  • CUTR
  • RGNX
Assets Removed
Asset Action Perf %
PAHC Buy All -6.77%
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.44% 7.75%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.06% 34.82%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.69% 6.55%
CYH Community Health Systems, Inc. Buy 7.09% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 6.21% -7.12%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.96% 4.01%
PDSB PDS Biotechnology Corporation Buy 6.9% 0%
BHVN Biohaven Ltd. Buy 6.9% 0%
ALT Altimmune, Inc. Buy 6.9% 0%
OPK OPKO Health, Inc. Buy 6.9% 0%
FGEN FibroGen, Inc. Sell -3.39% 12.33%
SGMO Sangamo Therapeutics, Inc. Sell -4.47% -11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.29% -3.17%
PAHC Phibro Animal Health Corporation Sell -3.57% 0%
CDNA CareDx, Inc Sell -3.57% 0%
The percentage of cash held in the portfolio is: 50.27%
New Assets Added
  • PAHC
  • CDNA
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.39% 7.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.03% 35.49%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.59% 6.02%
CYH Community Health Systems, Inc. Buy 6.99% 3.75%
VRDN Viridian Therapeutics, Inc. Buy 6.2% -6.59%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.99% 5.32%
FGEN FibroGen, Inc. Sell -3.13% 18.54%
SGMO Sangamo Therapeutics, Inc. Sell -3.88% 2.78%
APLS Apellis Pharmaceuticals, Inc. Sell -4.26% -3.44%
The percentage of cash held in the portfolio is: 70.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVRO Sell All -11.61%
Assets Rebalanced
None
2024-07-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 6.07% 2.77%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.93% 34.15%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.46% 4.12%
CYH Community Health Systems, Inc. Buy 6.8% 1.25%
NVRO Nevro Corp. Buy 6.43% -2.79%
VRDN Viridian Therapeutics, Inc. Buy 6.17% -6.81%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.79% 2.55%
FGEN FibroGen, Inc. Sell -3.01% 21.46%
SGMO Sangamo Therapeutics, Inc. Sell -3.54% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.19% -1.98%
The percentage of cash held in the portfolio is: 64.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
VERU Sell All -3.41%
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.82% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.28% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.28% 0.9%
CYH Community Health Systems, Inc. Buy 7.09% 5.31%
NVRO Nevro Corp. Buy 6.46% -2.67%
VRDN Viridian Therapeutics, Inc. Buy 6.15% -7.27%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.35% -4.36%
VERU Veru Inc. Buy 6.86% 3.41%
FGEN FibroGen, Inc. Sell -2.58% 32.91%
SGMO Sangamo Therapeutics, Inc. Sell -3.55% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -4.02% 2.42%
The percentage of cash held in the portfolio is: 57.86%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.88% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.88% 16.74%
STAA STAAR Surgical Company Buy 6.51% 5.2%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.36% 2.79%
CYH Community Health Systems, Inc. Buy 7.18% 7.19%
NVRO Nevro Corp. Buy 6.4% -3.02%
VRDN Viridian Therapeutics, Inc. Buy 6.08% -7.95%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.55% -0.77%
VERU Veru Inc. Buy 7.13% 7.95%
FGEN FibroGen, Inc. Sell -2.76% 27.86%
SGMO Sangamo Therapeutics, Inc. Sell -3.53% 11.11%
APLS Apellis Pharmaceuticals, Inc. Sell -3.96% 3.61%
The percentage of cash held in the portfolio is: 51.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.74% 1.01%
MNKD MannKind Corporation Buy 5.33% -6.26%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.02% 23.44%
STAA STAAR Surgical Company Buy 6.69% 12.05%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.16% 3.19%
CYH Community Health Systems, Inc. Buy 6.7% 3.75%
ARDX Ardelyx, Inc. Buy 6.95% 2.16%
CHRS Coherus BioSciences, Inc. Buy 6.33% -6.94%
NVRO Nevro Corp. Buy 6.37% 0%
VRDN Viridian Therapeutics, Inc. Buy 6.37% 0%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.37% 0%
VERU Veru Inc. Buy 6.37% 0%
FGEN FibroGen, Inc. Sell -2.75% 25.24%
SGMO Sangamo Therapeutics, Inc. Sell -3.51% 8.33%
APLS Apellis Pharmaceuticals, Inc. Sell -3.96% 0%
The percentage of cash held in the portfolio is: 33.83%
New Assets Added
  • APLS
  • NVRO
  • VRDN
  • RYTM
  • VERU
Assets Removed
Asset Action Perf %
NVRO Buy All -8.17%
MODV Buy All -8.11%
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.81% 2.33%
MNKD MannKind Corporation Buy 5.46% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.09% 25%
STAA STAAR Surgical Company Buy 6.7% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.15% 3.14%
CYH Community Health Systems, Inc. Buy 6.77% 5%
ARDX Ardelyx, Inc. Buy 6.79% 0%
CHRS Coherus BioSciences, Inc. Buy 6.79% 0%
NVRO Nevro Corp. Sell -3.89% -5.78%
MODV ModivCare Inc. Sell -3.82% -4.83%
FGEN FibroGen, Inc. Sell -3.18% 13.4%
SGMO Sangamo Therapeutics, Inc. Sell -3.82% 0%
The percentage of cash held in the portfolio is: 63.15%
New Assets Added
  • SGMO
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.93% 3.09%
MNKD MannKind Corporation Buy 5.6% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.44% 12.05%
STAA STAAR Surgical Company Buy 6.67% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.28% 3.94%
CYH Community Health Systems, Inc. Buy 6.54% 0%
NVRO Nevro Corp. Sell -3.92% -5.03%
MODV ModivCare Inc. Sell -3.73% -0.84%
FGEN FibroGen, Inc. Sell -3.73% 0%
The percentage of cash held in the portfolio is: 73.9%
New Assets Added
  • FGEN
  • CYH
Assets Removed
Asset Action Perf %
AVXL Buy All -12.3%
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.64% -2.39%
MNKD MannKind Corporation Buy 5.52% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 6.35% 9.82%
STAA STAAR Surgical Company Buy 6.52% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.17% 1.71%
NVRO Nevro Corp. Sell -4.01% -7.16%
MODV ModivCare Inc. Sell -3.71% 0%
AVXL Anavex Life Sciences Corp. Sell -3.71% 0%
The percentage of cash held in the portfolio is: 81.24%
New Assets Added
  • MODV
  • AVXL
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.68% -1.76%
MNKD MannKind Corporation Buy 5.58% -3.5%
FGEN FibroGen, Inc. Buy 5.64% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.88% 1.56%
STAA STAAR Surgical Company Buy 6.07% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 6.07% 0%
NVRO Nevro Corp. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 68.82%
New Assets Added
  • NVRO
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 5.76% 0%
MNKD MannKind Corporation Buy 5.76% 0%
FGEN FibroGen, Inc. Buy 5.76% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 76.94%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-06-06 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
SLP Buy All 5.86%
RCM Sell All 2%
Assets Rebalanced
None
2024-06-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -1.31% 2.32%
SLP Simulations Plus, Inc. Sell -3.18% 7.98%
The percentage of cash held in the portfolio is: 104.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
ICUI Buy All -6.33%
Assets Rebalanced
None
2024-05-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -1.33% 3.92%
ICUI ICU Medical, Inc. Sell -4.35% 0.44%
SLP Simulations Plus, Inc. Sell -3.37% 2.5%
The percentage of cash held in the portfolio is: 109.05%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Buy All 14.16%
Assets Rebalanced
None
2024-05-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -1.32% 3.04%
VRDN Viridian Therapeutics, Inc. Sell -2.77% 13.87%
ICUI ICU Medical, Inc. Sell -4.25% 2.74%
SLP Simulations Plus, Inc. Sell -3.35% 2.88%
The percentage of cash held in the portfolio is: 111.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
TVTX Buy All -12.87%
BKD Buy All 6.57%
Assets Rebalanced
None
2024-05-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -1.31% 2%
BKD Brookdale Senior Living Inc. Sell -3.64% 4.29%
VRDN Viridian Therapeutics, Inc. Sell -2.83% 12.37%
ICUI ICU Medical, Inc. Sell -4.42% -0.88%
TVTX Travere Therapeutics, Inc. Sell -4.89% -11.55%
SLP Simulations Plus, Inc. Sell -3.44% 0.46%
The percentage of cash held in the portfolio is: 120.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDRX Buy All -16.51%
VKTX Buy All 5.36%
ILMN Buy All 6.9%
Assets Rebalanced
None
2024-05-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy -1.27% -0.16%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.7% -0.53%
ILMN Illumina, Inc. Sell -3.47% 5.62%
BKD Brookdale Senior Living Inc. Sell -3.62% 3.57%
VRDN Viridian Therapeutics, Inc. Sell -2.78% 12.94%
VKTX Viking Therapeutics, Inc. Sell -3.78% 9.14%
ICUI ICU Medical, Inc. Sell -4.23% 2.22%
TVTX Travere Therapeutics, Inc. Sell -4.4% -1.65%
SLP Simulations Plus, Inc. Sell -3.4% 0.3%
The percentage of cash held in the portfolio is: 130.65%
New Assets Added
None
Assets Removed
Asset Action Perf %
AORT Sell All 13.62%
OMCL Sell All 8.3%
NUTX Sell All 9.74%
Assets Rebalanced
None
2024-05-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 7.86% 13%
OMCL Omnicell, Inc. Buy 7.4% 5.21%
NUTX Nutex Health Inc. Buy 6.98% 8.86%
RCM R1 RCM Inc. Buy -1.24% -2.92%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.82% -3.46%
ILMN Illumina, Inc. Sell -3.47% 6.18%
BKD Brookdale Senior Living Inc. Sell -3.6% 4.57%
VRDN Viridian Therapeutics, Inc. Sell -2.8% 12.58%
VKTX Viking Therapeutics, Inc. Sell -3.73% 10.85%
ICUI ICU Medical, Inc. Sell -4.36% -0.29%
TVTX Travere Therapeutics, Inc. Sell -4.55% -4.62%
SLP Simulations Plus, Inc. Sell -3.41% 0.62%
The percentage of cash held in the portfolio is: 108.74%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALT Sell All 2.78%
GKOS Sell All 2.29%
KIDS Sell All -0.25%
VCYT Sell All -7.38%
Assets Rebalanced
None
2024-05-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALT Altimmune, Inc. Buy 8.3% 9.74%
GKOS Glaukos Corporation Buy 7.69% 2.57%
KIDS OrthoPediatrics Corp. Buy 7.96% 4.21%
AORT Artivion, Inc. Buy 7.84% 13.52%
OMCL Omnicell, Inc. Buy 7.48% 7%
NUTX Nutex Health Inc. Buy 6.84% 7.38%
VCYT Veracyte, Inc. Buy 6.03% -3.91%
RCM R1 RCM Inc. Buy -1.23% -2.72%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.71% -1.2%
ILMN Illumina, Inc. Sell -3.49% 4.81%
BKD Brookdale Senior Living Inc. Sell -3.63% 3.14%
VRDN Viridian Therapeutics, Inc. Sell -2.91% 8.7%
VKTX Viking Therapeutics, Inc. Sell -3.79% 8.76%
ICUI ICU Medical, Inc. Sell -4.38% -1.55%
TVTX Travere Therapeutics, Inc. Sell -4.67% -8.25%
SLP Simulations Plus, Inc. Sell -3.41% 0%
The percentage of cash held in the portfolio is: 79.09%
New Assets Added
  • SLP
Assets Removed
Asset Action Perf %
ANGO Buy All -8.78%
PODD Sell All -2.32%
INGN Sell All 22.55%
SGMO Sell All 18.52%
ACRS Sell All -8.73%
Assets Rebalanced
None
2024-05-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 8.1% 22.13%
SGMO Sangamo Therapeutics, Inc. Buy 9.59% 11.11%
ACRS Aclaris Therapeutics, Inc. Buy 7.25% -6.35%
ALT Altimmune, Inc. Buy 8.15% 7.09%
GKOS Glaukos Corporation Buy 7.8% 3.33%
KIDS OrthoPediatrics Corp. Buy 7.97% 3.62%
AORT Artivion, Inc. Buy 7.79% 12.09%
OMCL Omnicell, Inc. Buy 7.45% 5.91%
NUTX Nutex Health Inc. Buy 6.88% 7.24%
VCYT Veracyte, Inc. Buy 6.12% -3.2%
RCM R1 RCM Inc. Buy -1.25% -1.76%
PODD Insulet Corporation Buy 5.6% -1.4%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.79% -2.53%
ILMN Illumina, Inc. Sell -3.52% 4.62%
BKD Brookdale Senior Living Inc. Sell -3.72% 1.57%
VRDN Viridian Therapeutics, Inc. Sell -2.97% 7.4%
VKTX Viking Therapeutics, Inc. Sell -3.89% 6.99%
ICUI ICU Medical, Inc. Sell -4.29% 1.2%
TVTX Travere Therapeutics, Inc. Sell -4.74% -9.08%
ANGO AngioDynamics, Inc. Sell -3.18% -0.86%
The percentage of cash held in the portfolio is: 48.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
SENS Sell All -3.49%
Assets Rebalanced
None
2024-05-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
SENS Senseonics Holdings, Inc. Buy 7.26% -3.7%
INGN Inogen, Inc. Buy 8.2% 24.26%
SGMO Sangamo Therapeutics, Inc. Buy 9.7% 12.96%
ACRS Aclaris Therapeutics, Inc. Buy 7.27% -5.56%
ALT Altimmune, Inc. Buy 8.47% 11.82%
GKOS Glaukos Corporation Buy 7.81% 4.04%
KIDS OrthoPediatrics Corp. Buy 7.82% 2.26%
AORT Artivion, Inc. Buy 7.87% 13.76%
OMCL Omnicell, Inc. Buy 7.13% 1.99%
NUTX Nutex Health Inc. Buy 6.77% 6.21%
VCYT Veracyte, Inc. Buy 6.23% -0.89%
RCM R1 RCM Inc. Buy -1.24% -2.08%
PODD Insulet Corporation Buy 5.61% -0.67%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.79% -3.2%
ILMN Illumina, Inc. Sell -3.53% 3.8%
BKD Brookdale Senior Living Inc. Sell -3.68% 2%
VRDN Viridian Therapeutics, Inc. Sell -3.1% 2.73%
VKTX Viking Therapeutics, Inc. Sell -4.07% 2.24%
ICUI ICU Medical, Inc. Sell -4.29% 0.72%
TVTX Travere Therapeutics, Inc. Sell -4.4% -1.82%
ANGO AngioDynamics, Inc. Sell -3.14% 0%
The percentage of cash held in the portfolio is: 41.11%
New Assets Added
  • ANGO
Assets Removed
Asset Action Perf %
ALGN Buy All 12.26%
CARA Sell All -0.79%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 8.04% -0.79%
SENS Senseonics Holdings, Inc. Buy 7.44% -0.41%
INGN Inogen, Inc. Buy 8.19% 25.25%
SGMO Sangamo Therapeutics, Inc. Buy 10.25% 20.37%
ACRS Aclaris Therapeutics, Inc. Buy 7.21% -5.56%
ALT Altimmune, Inc. Buy 8.37% 11.4%
GKOS Glaukos Corporation Buy 7.78% 4.53%
KIDS OrthoPediatrics Corp. Buy 7.63% 0.66%
AORT Artivion, Inc. Buy 7.69% 12.09%
OMCL Omnicell, Inc. Buy 7.01% 1.03%
NUTX Nutex Health Inc. Buy 6.63% 4.74%
VCYT Veracyte, Inc. Buy 6.34% 1.69%
RCM R1 RCM Inc. Buy -1.25% -0.56%
PODD Insulet Corporation Buy 5.66% 1.02%
ALGN Align Technology, Inc. Sell -3.44% 10.93%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.66% -0.53%
ILMN Illumina, Inc. Sell -3.59% 1.55%
BKD Brookdale Senior Living Inc. Sell -3.68% 1.29%
VRDN Viridian Therapeutics, Inc. Sell -3.06% 3.31%
VKTX Viking Therapeutics, Inc. Sell -4% 2.98%
ICUI ICU Medical, Inc. Sell -4.29% 0%
TVTX Travere Therapeutics, Inc. Sell -4.29% 0%
The percentage of cash held in the portfolio is: 33.01%
New Assets Added
  • ICUI
  • TVTX
Assets Removed
Asset Action Perf %
IBRX Sell All -14.91%
PTCT Sell All 15.84%
RYTM Sell All -8.38%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 8.17% 19.11%
CARA Cara Therapeutics, Inc. Buy 8.51% 6.48%
IBRX ImmunityBio, Inc. Buy 7.13% -13.79%
SENS Senseonics Holdings, Inc. Buy 7.44% 1.03%
INGN Inogen, Inc. Buy 8.19% 26.95%
SGMO Sangamo Therapeutics, Inc. Buy 9.48% 12.96%
ACRS Aclaris Therapeutics, Inc. Buy 7.05% -6.35%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.33% -5.45%
ALT Altimmune, Inc. Buy 9.16% 23.78%
GKOS Glaukos Corporation Buy 7.72% 5.12%
KIDS OrthoPediatrics Corp. Buy 7.47% -0.06%
AORT Artivion, Inc. Buy 7.59% 12.28%
OMCL Omnicell, Inc. Buy 7.19% 5.08%
NUTX Nutex Health Inc. Buy 6.76% 8.41%
VCYT Veracyte, Inc. Buy 6.39% 4%
RCM R1 RCM Inc. Buy -1.22% -1.52%
PODD Insulet Corporation Buy 5.52% 0%
ALGN Align Technology, Inc. Sell -3.42% 10.26%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.75% -4.53%
ILMN Illumina, Inc. Sell -3.64% -1.45%
BKD Brookdale Senior Living Inc. Sell -3.71% -1%
VRDN Viridian Therapeutics, Inc. Sell -3.28% -5.18%
VKTX Viking Therapeutics, Inc. Sell -4.07% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VKTX
  • PODD
Assets Removed
Asset Action Perf %
NVRO Buy All 1.33%
MD Sell All -8.68%
Assets Rebalanced
None
2024-05-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 8.13% 17.82%
CARA Cara Therapeutics, Inc. Buy 8.08% 0.53%
IBRX ImmunityBio, Inc. Buy 7.49% -9.9%
SENS Senseonics Holdings, Inc. Buy 7.55% 1.85%
INGN Inogen, Inc. Buy 8.13% 25.39%
SGMO Sangamo Therapeutics, Inc. Buy 9.06% 7.41%
ACRS Aclaris Therapeutics, Inc. Buy 7.09% -6.35%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.45% -4.42%
ALT Altimmune, Inc. Buy 9.19% 23.37%
GKOS Glaukos Corporation Buy 7.83% 6.06%
KIDS OrthoPediatrics Corp. Buy 7.41% -1.38%
AORT Artivion, Inc. Buy 7.71% 13.38%
OMCL Omnicell, Inc. Buy 6.82% -0.86%
NUTX Nutex Health Inc. Buy 6.62% 5.62%
MD Pediatrix Medical Group, Inc. Buy 5.94% -3.87%
VCYT Veracyte, Inc. Buy 6.47% 4.67%
RCM R1 RCM Inc. Buy -1.25% 0%
NVRO Nevro Corp. Sell -3.94% 6.71%
ALGN Align Technology, Inc. Sell -3.52% 8.04%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.61% 0.13%
ILMN Illumina, Inc. Sell -3.68% -1.94%
BKD Brookdale Senior Living Inc. Sell -3.76% -1.71%
VRDN Viridian Therapeutics, Inc. Sell -3.21% -2.59%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
FOLD Buy All -6.86%
ITGR Buy All -7.43%
WST Sell All -4.6%
Assets Rebalanced
None
2024-05-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.85% 10.96%
CARA Cara Therapeutics, Inc. Buy 8.17% -0.79%
IBRX ImmunityBio, Inc. Buy 8.18% -4%
SENS Senseonics Holdings, Inc. Buy 6.93% -8.83%
INGN Inogen, Inc. Buy 8.31% 25.04%
SGMO Sangamo Therapeutics, Inc. Buy 8.81% 1.85%
ACRS Aclaris Therapeutics, Inc. Buy 7.26% -6.35%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.76% -2.97%
ALT Altimmune, Inc. Buy 7.82% 2.5%
GKOS Glaukos Corporation Buy 7.81% 3.17%
KIDS OrthoPediatrics Corp. Buy 7.54% -2.14%
WST West Pharmaceutical Services, Inc. Buy 7.34% -2.79%
AORT Artivion, Inc. Buy 7.72% 10.85%
OMCL Omnicell, Inc. Buy 7.21% 2.22%
NUTX Nutex Health Inc. Buy 6.61% 2.82%
MD Pediatrix Medical Group, Inc. Buy 6.33% 0%
VCYT Veracyte, Inc. Buy 6.33% 0%
ITGR Integer Holdings Corporation Sell -4.45% -2.84%
NVRO Nevro Corp. Sell -3.9% 9.98%
ALGN Align Technology, Inc. Sell -3.51% 10.52%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.81% -2.8%
ILMN Illumina, Inc. Sell -3.7% 0.04%
BKD Brookdale Senior Living Inc. Sell -3.78% 0.14%
VRDN Viridian Therapeutics, Inc. Sell -3.31% -3.09%
FOLD Amicus Therapeutics, Inc. Sell -3.53% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • FOLD
  • MD
  • VCYT
Assets Removed
Asset Action Perf %
MD Buy All -0.35%
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 8.07% 12.88%
CARA Cara Therapeutics, Inc. Buy 7.88% -5.29%
IBRX ImmunityBio, Inc. Buy 7.78% -9.68%
SENS Senseonics Holdings, Inc. Buy 7.35% -4.31%
INGN Inogen, Inc. Buy 8.06% 20%
SGMO Sangamo Therapeutics, Inc. Buy 9.07% 3.7%
ACRS Aclaris Therapeutics, Inc. Buy 7.28% -7.14%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.63% -5.53%
ALT Altimmune, Inc. Buy 7.75% 0.42%
GKOS Glaukos Corporation Buy 8.04% 5.17%
KIDS OrthoPediatrics Corp. Buy 7.61% -2.26%
WST West Pharmaceutical Services, Inc. Buy 7.54% -1.16%
AORT Artivion, Inc. Buy 7.92% 12.42%
OMCL Omnicell, Inc. Buy 7.12% -0.03%
NUTX Nutex Health Inc. Buy 6.03% -7.18%
ITGR Integer Holdings Corporation Sell -4.55% -4.01%
NVRO Nevro Corp. Sell -3.79% 13.52%
ALGN Align Technology, Inc. Sell -3.54% 10.87%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.88% -3.73%
ILMN Illumina, Inc. Sell -3.67% 2.03%
MD Pediatrix Medical Group, Inc. Sell -3.7% 3.29%
BKD Brookdale Senior Living Inc. Sell -3.86% -0.86%
VRDN Viridian Therapeutics, Inc. Sell -3.24% 0.07%
The percentage of cash held in the portfolio is: 15.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
IOVA Sell All -12.24%
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.6% 8.68%
CARA Cara Therapeutics, Inc. Buy 8.18% 0.53%
IBRX ImmunityBio, Inc. Buy 7.55% -10.34%
SENS Senseonics Holdings, Inc. Buy 7.41% -1.23%
INGN Inogen, Inc. Buy 8.1% 23.26%
IOVA Iovance Biotherapeutics, Inc. Buy 7.07% 7.6%
SGMO Sangamo Therapeutics, Inc. Buy 8.23% -3.7%
ACRS Aclaris Therapeutics, Inc. Buy 7.45% -2.78%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.34% -7.07%
ALT Altimmune, Inc. Buy 8.1% 7.37%
GKOS Glaukos Corporation Buy 7.66% 2.47%
KIDS OrthoPediatrics Corp. Buy 8.02% 5.28%
WST West Pharmaceutical Services, Inc. Buy 7.4% -0.78%
AORT Artivion, Inc. Buy 7.7% 11.8%
OMCL Omnicell, Inc. Buy 7% 0.4%
NUTX Nutex Health Inc. Buy 6.17% -2.91%
ITGR Integer Holdings Corporation Sell -4.46% -4.24%
NVRO Nevro Corp. Sell -3.98% 7.16%
ALGN Align Technology, Inc. Sell -3.57% 8.01%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.78% -3.2%
ILMN Illumina, Inc. Sell -3.61% 1.3%
MD Pediatrix Medical Group, Inc. Sell -3.6% 3.88%
BKD Brookdale Senior Living Inc. Sell -3.83% -2.43%
VRDN Viridian Therapeutics, Inc. Sell -3.17% 0%
The percentage of cash held in the portfolio is: 8.99%
New Assets Added
  • VRDN
Assets Removed
Asset Action Perf %
ACHC Buy All -6.61%
CDMO Sell All 7.67%
Assets Rebalanced
None
2024-05-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.73% 9%
CARA Cara Therapeutics, Inc. Buy 8.01% -3.04%
CDMO Avid Bioservices, Inc. Buy 7% 10.85%
IBRX ImmunityBio, Inc. Buy 7.53% -11.9%
SENS Senseonics Holdings, Inc. Buy 7.44% -2.26%
INGN Inogen, Inc. Buy 7.79% 16.88%
IOVA Iovance Biotherapeutics, Inc. Buy 7.14% 7.12%
SGMO Sangamo Therapeutics, Inc. Buy 8.03% -7.41%
ACRS Aclaris Therapeutics, Inc. Buy 7.53% -3.17%
RYTM Rhythm Pharmaceuticals, Inc. Buy 7.53% -6.06%
ALT Altimmune, Inc. Buy 7.62% -0.42%
GKOS Glaukos Corporation Buy 7.72% 1.79%
KIDS OrthoPediatrics Corp. Buy 8.06% 4.31%
WST West Pharmaceutical Services, Inc. Buy 7.53% -0.49%
AORT Artivion, Inc. Buy 7.78% 11.32%
OMCL Omnicell, Inc. Buy 7.03% -0.56%
NUTX Nutex Health Inc. Buy 6.13% -4.82%
ITGR Integer Holdings Corporation Sell -4.48% -3.25%
NVRO Nevro Corp. Sell -3.9% 10.25%
ALGN Align Technology, Inc. Sell -3.54% 10.23%
ACHC Acadia Healthcare Company, Inc. Sell -3.09% 0.09%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.76% -1.33%
ILMN Illumina, Inc. Sell -3.64% 1.95%
MD Pediatrix Medical Group, Inc. Sell -3.79% 0%
BKD Brookdale Senior Living Inc. Sell -3.79% 0%
The percentage of cash held in the portfolio is: 2.4%
New Assets Added
  • MD
  • BKD
Assets Removed
None
Assets Rebalanced
Asset Action Weight
CARA Buy 0.4%
SGMO Buy 0.51%
KIDS Buy 0.58%
WST Buy 0.9%
IBRX Buy 1.05%
ACRS Buy 1.08%
RYTM Buy 1.27%
2024-05-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.73% 11.27%
CARA Cara Therapeutics, Inc. Buy 7.55% 4.76%
CDMO Avid Bioservices, Inc. Buy 7.17% 15.87%
IBRX ImmunityBio, Inc. Buy 6.62% -8.12%
SENS Senseonics Holdings, Inc. Buy 7.68% 2.87%
IOVA Iovance Biotherapeutics, Inc. Buy 7.3% 11.84%
SGMO Sangamo Therapeutics, Inc. Buy 7.43% 0%
ACRS Aclaris Therapeutics, Inc. Buy 6.94% 6.35%
INGN Inogen, Inc. Buy 6.76% 3.55%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.2% -5.02%
KIDS OrthoPediatrics Corp. Buy 7.12% 9.09%
GKOS Glaukos Corporation Buy 7.64% 2.81%
ALT Altimmune, Inc. Buy 7.58% 1.11%
WST West Pharmaceutical Services, Inc. Buy 6.53% -0.03%
AORT Artivion, Inc. Buy 7.77% 13.57%
OMCL Omnicell, Inc. Buy 6.96% 0.56%
NUTX Nutex Health Inc. Buy 5.66% -10.41%
ITGR Integer Holdings Corporation Sell -4.39% -3.25%
NVRO Nevro Corp. Sell -4.33% -1.86%
ALGN Align Technology, Inc. Sell -3.63% 6%
ACHC Acadia Healthcare Company, Inc. Sell -3.09% -1.98%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.64% 0%
ILMN Illumina, Inc. Sell -3.64% 0%
The percentage of cash held in the portfolio is: 2.07%
New Assets Added
  • MDRX
  • ILMN
Assets Removed
Asset Action Perf %
OFIX Buy All -6.93%
Assets Rebalanced
Asset Action Weight
PTCT Buy 0.45%
ALT Buy 0.5%
SENS Buy 0.64%
2024-05-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 6.93% 15.37%
CARA Cara Therapeutics, Inc. Buy 7.57% 4.5%
IBRX ImmunityBio, Inc. Buy 6.3% -13.13%
CDMO Avid Bioservices, Inc. Buy 6.93% 11.38%
SENS Senseonics Holdings, Inc. Buy 6.54% 3.49%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.95% 5.91%
IOVA Iovance Biotherapeutics, Inc. Buy 7.29% 11.04%
ACRS Aclaris Therapeutics, Inc. Buy 6.83% 3.97%
INGN Inogen, Inc. Buy 6.7% 1.99%
SGMO Sangamo Therapeutics, Inc. Buy 7.33% -1.85%
KIDS OrthoPediatrics Corp. Buy 6.93% 5.63%
ALT Altimmune, Inc. Buy 6.72% 2.36%
GKOS Glaukos Corporation Buy 7.47% -0.02%
WST West Pharmaceutical Services, Inc. Buy 6.53% -0.52%
OMCL Omnicell, Inc. Buy 6.93% -0.5%
AORT Artivion, Inc. Buy 6.93% 0.67%
NUTX Nutex Health Inc. Buy 6.29% -1%
OFIX Orthofix Medical Inc. Sell -4.43% -3.62%
ITGR Integer Holdings Corporation Sell -4.36% -1.96%
NVRO Nevro Corp. Sell -4.21% 1.5%
ALGN Align Technology, Inc. Sell -3.66% 5.72%
ACHC Acadia Healthcare Company, Inc. Sell -3.13% -2.51%
The percentage of cash held in the portfolio is: 2.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATRI Buy All -10.12%
Assets Rebalanced
Asset Action Weight
SENS Sell -0.96%
NUTX Sell -1.66%
OMCL Sell -1.06%
PTCT Sell -1.13%
CDMO Sell -1.14%
AORT Sell -1.15%
GKOS Buy 0.37%
SGMO Buy 0.48%
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.97% 15.54%
IBRX ImmunityBio, Inc. Buy 7.28% 1.78%
CDMO Avid Bioservices, Inc. Buy 7.8% 9.13%
CARA Cara Therapeutics, Inc. Buy 7.36% 2.94%
SENS Senseonics Holdings, Inc. Buy 7.41% 3.68%
INGN Inogen, Inc. Buy 6.57% 1.42%
ACRS Aclaris Therapeutics, Inc. Buy 6.99% 7.94%
IOVA Iovance Biotherapeutics, Inc. Buy 7.06% 9.04%
SGMO Sangamo Therapeutics, Inc. Buy 6.67% 2.93%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.84% 5.62%
GKOS Glaukos Corporation Buy 6.57% 1.41%
WST West Pharmaceutical Services, Inc. Buy 6.42% -0.93%
KIDS OrthoPediatrics Corp. Buy 6.69% 3.21%
ALT Altimmune, Inc. Buy 6.58% 1.53%
OMCL Omnicell, Inc. Buy 7.92% 0%
NUTX Nutex Health Inc. Buy 7.92% 0%
AORT Artivion, Inc. Buy 7.92% 0%
ATRI Atrion Corporation Sell -4.43% -5.05%
NVRO Nevro Corp. Sell -4.21% 0.27%
ITGR Integer Holdings Corporation Sell -4.29% -1.54%
OFIX Orthofix Medical Inc. Sell -4.42% -4.7%
ALGN Align Technology, Inc. Sell -3.62% 5.56%
ACHC Acadia Healthcare Company, Inc. Sell -3.01% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ACHC
  • OMCL
  • NUTX
  • AORT
Assets Removed
Asset Action Perf %
SMMT Sell All 13.73%
Assets Rebalanced
None
2024-05-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 8.3% 17.68%
SMMT Summit Therapeutics Inc. Buy 7.42% 5.18%
IBRX ImmunityBio, Inc. Buy 7.3% -0.22%
CDMO Avid Bioservices, Inc. Buy 7.93% 8.47%
CARA Cara Therapeutics, Inc. Buy 7.47% 2.12%
SENS Senseonics Holdings, Inc. Buy 7.78% 6.37%
INGN Inogen, Inc. Buy 6.61% -0.28%
ACRS Aclaris Therapeutics, Inc. Buy 6.89% 3.97%
IOVA Iovance Biotherapeutics, Inc. Buy 6.83% 3.04%
SGMO Sangamo Therapeutics, Inc. Buy 6.38% -3.7%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.55% -1.09%
GKOS Glaukos Corporation Buy 6.62% 0%
WST West Pharmaceutical Services, Inc. Buy 6.62% 0%
KIDS OrthoPediatrics Corp. Buy 6.62% 0%
ALT Altimmune, Inc. Buy 6.62% 0%
ATRI Atrion Corporation Sell -4.54% -5.05%
NVRO Nevro Corp. Sell -4.25% 1.5%
ITGR Integer Holdings Corporation Sell -4.33% -0.31%
OFIX Orthofix Medical Inc. Sell -4.4% -1.92%
ALGN Align Technology, Inc. Sell -3.68% 6%
The percentage of cash held in the portfolio is: 15.25%
New Assets Added
  • GKOS
  • WST
  • KIDS
  • ALT
Assets Removed
None
Assets Rebalanced
None
2024-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 8.47% 19.57%
SMMT Summit Therapeutics Inc. Buy 8.62% 21.76%
IBRX ImmunityBio, Inc. Buy 6.97% -5.01%
CDMO Avid Bioservices, Inc. Buy 7.45% 1.46%
CARA Cara Therapeutics, Inc. Buy 7.37% 0.4%
SENS Senseonics Holdings, Inc. Buy 6.98% -4.93%
INGN Inogen, Inc. Buy 6.65% 0%
ACRS Aclaris Therapeutics, Inc. Buy 6.65% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 6.65% 0%
SGMO Sangamo Therapeutics, Inc. Buy 6.65% 0%
RYTM Rhythm Pharmaceuticals, Inc. Buy 6.65% 0%
ATRI Atrion Corporation Sell -4.68% -8.07%
NVRO Nevro Corp. Sell -3.99% 8.04%
ITGR Integer Holdings Corporation Sell -4.34% -0.18%
OFIX Orthofix Medical Inc. Sell -4.35% -0.31%
ALGN Align Technology, Inc. Sell -3.67% 6.66%
The percentage of cash held in the portfolio is: 41.91%
New Assets Added
  • INGN
  • ACRS
  • IOVA
  • SGMO
  • RYTM
Assets Removed
Asset Action Perf %
NUTX Buy All 37.91%
BKD Buy All -5.26%
FATE Buy All 34.77%
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 8.13% 12.53%
SMMT Summit Therapeutics Inc. Buy 7.35% 1.81%
IBRX ImmunityBio, Inc. Buy 6.66% -11.12%
CDMO Avid Bioservices, Inc. Buy 7.56% 0.93%
CARA Cara Therapeutics, Inc. Buy 7.45% -0.53%
SENS Senseonics Holdings, Inc. Buy 7.49% 0%
NUTX Nutex Health Inc. Sell -2.05% 38.01%
BKD Brookdale Senior Living Inc. Sell -3.37% -1.95%
FATE Fate Therapeutics, Inc. Sell -2.08% 37%
ATRI Atrion Corporation Sell -4.74% -7.16%
NVRO Nevro Corp. Sell -4.13% 6.54%
ITGR Integer Holdings Corporation Sell -4.5% -1.87%
OFIX Orthofix Medical Inc. Sell -4.43% -0.08%
ALGN Align Technology, Inc. Sell -3.71% 7.36%
The percentage of cash held in the portfolio is: 84.39%
New Assets Added
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 8.14% 12.5%
SMMT Summit Therapeutics Inc. Buy 7.28% 0.52%
IBRX ImmunityBio, Inc. Buy 7.51% 0%
CDMO Avid Bioservices, Inc. Buy 7.51% 0%
CARA Cara Therapeutics, Inc. Buy 7.51% 0%
NUTX Nutex Health Inc. Sell -2.13% 35.86%
BKD Brookdale Senior Living Inc. Sell -3.44% -3.75%
FATE Fate Therapeutics, Inc. Sell -2.14% 35.57%
ATRI Atrion Corporation Sell -4.71% -6.33%
NVRO Nevro Corp. Sell -4.47% -0.88%
ITGR Integer Holdings Corporation Sell -4.63% -4.55%
OFIX Orthofix Medical Inc. Sell -4.47% -0.77%
ALGN Align Technology, Inc. Sell -4.02% 0%
The percentage of cash held in the portfolio is: 92.07%
New Assets Added
  • ALGN
  • IBRX
  • CDMO
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 7.27% 0%
SMMT Summit Therapeutics Inc. Buy 7.27% 0%
NUTX Nutex Health Inc. Sell -2.26% 32.17%
BKD Brookdale Senior Living Inc. Sell -3.48% -4.5%
FATE Fate Therapeutics, Inc. Sell -2.02% 39.39%
ATRI Atrion Corporation Sell -4.45% 0%
NVRO Nevro Corp. Sell -4.45% 0%
ITGR Integer Holdings Corporation Sell -4.45% 0%
OFIX Orthofix Medical Inc. Sell -4.45% 0%
The percentage of cash held in the portfolio is: 111.02%
New Assets Added
  • ATRI
  • NVRO
  • ITGR
  • OFIX
  • PTCT
  • SMMT
Assets Removed
None
Assets Rebalanced
None
2024-04-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Sell -2.36% 29.41%
BKD Brookdale Senior Living Inc. Sell -3.31% 0.9%
FATE Fate Therapeutics, Inc. Sell -2.55% 23.76%
The percentage of cash held in the portfolio is: 108.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All -6.11%
Assets Rebalanced
None
2024-04-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.55% -6.11%
NUTX Nutex Health Inc. Sell -2.24% 32.89%
BKD Brookdale Senior Living Inc. Sell -3.27% 2.1%
FATE Fate Therapeutics, Inc. Sell -2.69% 19.62%
The percentage of cash held in the portfolio is: 97.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
UTHR Buy All -3.14%
Assets Rebalanced
None
2024-04-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.71% -4.58%
UTHR United Therapeutics Corporation Sell -6.8% -2.43%
NUTX Nutex Health Inc. Sell -2.26% 32.17%
BKD Brookdale Senior Living Inc. Sell -3.24% 3%
FATE Fate Therapeutics, Inc. Sell -2.81% 15.95%
The percentage of cash held in the portfolio is: 104.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
ANGO Sell All 11.05%
KIDS Sell All 3.21%
ACRS Sell All -2.38%
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 11.25% 10.7%
KIDS OrthoPediatrics Corp. Buy 10.68% 5.11%
ACRS Aclaris Therapeutics, Inc. Buy 9.76% -3.97%
OPK OPKO Health, Inc. Buy 10.52% -6.11%
UTHR United Therapeutics Corporation Sell -6.78% -2.33%
NUTX Nutex Health Inc. Sell -1.82% 45.39%
BKD Brookdale Senior Living Inc. Sell -3.16% 5.11%
FATE Fate Therapeutics, Inc. Sell -3% 10.05%
The percentage of cash held in the portfolio is: 72.56%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All -9.75%
Assets Rebalanced
None
2024-04-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 11.32% 11.75%
TNDM Tandem Diabetes Care, Inc. Buy 9.62% -5.1%
KIDS OrthoPediatrics Corp. Buy 10.87% 7.32%
ACRS Aclaris Therapeutics, Inc. Buy 9.73% -3.97%
OPK OPKO Health, Inc. Buy 10.49% -6.11%
UTHR United Therapeutics Corporation Sell -6.69% -1.25%
NUTX Nutex Health Inc. Sell -2.29% 31.25%
BKD Brookdale Senior Living Inc. Sell -3.23% 2.85%
FATE Fate Therapeutics, Inc. Sell -3.06% 7.97%
The percentage of cash held in the portfolio is: 63.23%
New Assets Added
None
Assets Removed
Asset Action Perf %
RVNC Sell All -16.06%
Assets Rebalanced
None
2024-04-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 12.13% 20.18%
TNDM Tandem Diabetes Care, Inc. Buy 9.88% -2.07%
KIDS OrthoPediatrics Corp. Buy 11.07% 9.67%
ACRS Aclaris Therapeutics, Inc. Buy 9.29% -7.94%
RVNC Revance Therapeutics, Inc. Buy 9.54% -10.37%
OPK OPKO Health, Inc. Buy 10.79% -3.05%
UTHR United Therapeutics Corporation Sell -6.81% -3.51%
NUTX Nutex Health Inc. Sell -3.31% 0%
BKD Brookdale Senior Living Inc. Sell -3.31% 0%
FATE Fate Therapeutics, Inc. Sell -3.31% 0%
The percentage of cash held in the portfolio is: 54.05%
New Assets Added
  • NUTX
  • BKD
  • FATE
Assets Removed
Asset Action Perf %
LXRX Sell All -15.83%
Assets Rebalanced
None
2024-04-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 12.12% 22.28%
TNDM Tandem Diabetes Care, Inc. Buy 9.79% -1.16%
KIDS OrthoPediatrics Corp. Buy 10.4% 4.94%
ACRS Aclaris Therapeutics, Inc. Buy 9.36% -5.56%
RVNC Revance Therapeutics, Inc. Buy 9.96% -4.67%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.01% -13.75%
OPK OPKO Health, Inc. Buy 11.51% 5.34%
UTHR United Therapeutics Corporation Sell -6.67% -3.19%
The percentage of cash held in the portfolio is: 34.52%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Buy All -1111.05%
Assets Rebalanced
None
2024-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 6.41% 8.6%
TNDM Tandem Diabetes Care, Inc. Buy 5.61% -5.1%
KIDS OrthoPediatrics Corp. Buy 5.44% -7.9%
ACRS Aclaris Therapeutics, Inc. Buy 5.72% -3.17%
RVNC Revance Therapeutics, Inc. Buy 5.71% -8.33%
LXRX Lexicon Pharmaceuticals, Inc. Buy 5.73% -7.92%
OPK OPKO Health, Inc. Buy 6.71% 3.05%
UTHR United Therapeutics Corporation Sell -3.83% 0.5%
NUTX Nutex Health Inc. Sell -3.73% 1.05%
The percentage of cash held in the portfolio is: 66.23%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -5.57%
Assets Rebalanced
None
2024-04-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 6% 2.28%
TNDM Tandem Diabetes Care, Inc. Buy 5.62% -4.11%
KIDS OrthoPediatrics Corp. Buy 5.71% -2.69%
ACRS Aclaris Therapeutics, Inc. Buy 5.86% 0%
VCYT Veracyte, Inc. Buy 5.84% -0.37%
RVNC Revance Therapeutics, Inc. Buy 5.94% -3.86%
LXRX Lexicon Pharmaceuticals, Inc. Buy 5.87% -5%
OPK OPKO Health, Inc. Buy 6.47% 0%
UTHR United Therapeutics Corporation Sell -3.8% 0.64%
NUTX Nutex Health Inc. Sell -3.74% 0%
The percentage of cash held in the portfolio is: 60.22%
New Assets Added
  • NUTX
  • OPK
Assets Removed
Asset Action Perf %
OFIX Sell All -3.17%
ATRI Sell All -11.81%
Assets Rebalanced
None
2024-03-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.92% 2.98%
TNDM Tandem Diabetes Care, Inc. Buy 5.77% 0.31%
KIDS OrthoPediatrics Corp. Buy 5.79% 0.66%
ACRS Aclaris Therapeutics, Inc. Buy 5.66% -1.59%
VCYT Veracyte, Inc. Buy 5.87% 2.03%
ATRI Atrion Corporation Buy 6.06% 0%
OFIX Orthofix Medical Inc. Buy 6.06% 0%
RVNC Revance Therapeutics, Inc. Buy 6.06% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.06% 0%
UTHR United Therapeutics Corporation Sell -3.75% 0%
The percentage of cash held in the portfolio is: 50.5%
New Assets Added
  • UTHR
  • ATRI
  • OFIX
  • RVNC
  • LXRX
Assets Removed
None
Assets Rebalanced
None
2024-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.76% 0%
TNDM Tandem Diabetes Care, Inc. Buy 5.76% 0%
KIDS OrthoPediatrics Corp. Buy 5.76% 0%
ACRS Aclaris Therapeutics, Inc. Buy 5.76% 0%
VCYT Veracyte, Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 71.18%
New Assets Added
  • ANGO
  • TNDM
  • KIDS
  • ACRS
  • VCYT
Assets Removed
Asset Action Perf %
SMTI Buy All -1.39%
BAX Sell All -0.7%
OMCL Sell All 5.22%
ADMA Sell All 10.13%
Assets Rebalanced
None
2024-03-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 7.95% -2.79%
OMCL Omnicell, Inc. Buy 8.36% 2.2%
ADMA ADMA Biologics, Inc. Buy 8.54% 4.41%
SMTI Sanara MedTech Inc. Sell -5.54% 1.47%
The percentage of cash held in the portfolio is: 80.7%
New Assets Added
None
Assets Removed
Asset Action Perf %
BHVN Sell All -2.06%
RGNX Sell All 1.08%
Assets Rebalanced
None
2024-03-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
BHVN Biohaven Ltd. Buy 7.78% -0.96%
RGNX REGENXBIO Inc. Buy 8.01% 1.97%
BAX Baxter International Inc. Buy 8% -2.44%
OMCL Omnicell, Inc. Buy 8.24% 0.5%
ADMA ADMA Biologics, Inc. Buy 8.43% 2.78%
SMTI Sanara MedTech Inc. Sell -5.73% -1.69%
The percentage of cash held in the portfolio is: 65.28%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Buy All 10.62%
THC Sell All 8.23%
RDNT Sell All 8.32%
NTRA Sell All 3.25%
Assets Rebalanced
None
2024-03-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 8.64% 8.8%
RDNT RadNet, Inc. Buy 8.45% 6.45%
NTRA Natera, Inc. Buy 8.25% 3.9%
BHVN Biohaven Ltd. Buy 8.23% 5.27%
RGNX REGENXBIO Inc. Buy 8.24% 5.38%
BAX Baxter International Inc. Buy 7.94% -2.7%
OMCL Omnicell, Inc. Buy 8.2% 0.5%
ADMA ADMA Biologics, Inc. Buy 8.43% 3.27%
ORGO Organogenesis Holdings Inc. Sell -3.16% 4.11%
SMTI Sanara MedTech Inc. Sell -5.75% -2.45%
The percentage of cash held in the portfolio is: 42.54%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCKT Buy All 4.03%
CUTR Buy All -7.11%
XNCR Buy All 0.18%
QTRX Sell All -9.55%
Assets Rebalanced
None
2024-03-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 8.5% 6.46%
RDNT RadNet, Inc. Buy 8.07% 1.08%
NTRA Natera, Inc. Buy 8.05% 0.79%
QTRX Quanterix Corporation Buy 7.45% -5.31%
BHVN Biohaven Ltd. Buy 7.91% 0.62%
RGNX REGENXBIO Inc. Buy 8.22% 4.54%
BAX Baxter International Inc. Buy 7.94% -3.37%
OMCL Omnicell, Inc. Buy 8.12% -1.15%
ADMA ADMA Biologics, Inc. Buy 7.97% -2.94%
CUTR Cutera, Inc. Sell -3.45% 7.11%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.4% 8.65%
XNCR Xencor, Inc. Sell -3.63% 2.37%
ORGO Organogenesis Holdings Inc. Sell -3.12% 5.82%
SMTI Sanara MedTech Inc. Sell -5.59% 1.03%
The percentage of cash held in the portfolio is: 46.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
ABUS Sell All -5.93%
Assets Rebalanced
None
2024-03-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 8.42% 4.78%
RDNT RadNet, Inc. Buy 8.05% 0.23%
NTRA Natera, Inc. Buy 8.05% 0.12%
QTRX Quanterix Corporation Buy 7.48% -5.42%
BHVN Biohaven Ltd. Buy 8.01% 1.21%
RGNX REGENXBIO Inc. Buy 8.22% 3.89%
BAX Baxter International Inc. Buy 8% -3.21%
OMCL Omnicell, Inc. Buy 8.23% -0.36%
ADMA ADMA Biologics, Inc. Buy 8.09% -2.12%
ABUS Arbutus Biopharma Corporation Buy 6.08% -2.96%
CUTR Cutera, Inc. Sell -3.78% -1.02%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.46% 7.65%
XNCR Xencor, Inc. Sell -3.79% -1.32%
ORGO Organogenesis Holdings Inc. Sell -3.25% 2.4%
SMTI Sanara MedTech Inc. Sell -5.71% -0.57%
The percentage of cash held in the portfolio is: 41.36%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTGX Sell All 1.76%
Assets Rebalanced
None
2024-03-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 7.12% -0.46%
THC Tenet Healthcare Corporation Buy 8.55% 6.1%
RDNT RadNet, Inc. Buy 7.97% -1.08%
NTRA Natera, Inc. Buy 7.9% -1.9%
QTRX Quanterix Corporation Buy 7.45% -6.02%
BHVN Biohaven Ltd. Buy 7.93% 0.05%
RGNX REGENXBIO Inc. Buy 8.11% 2.29%
BAX Baxter International Inc. Buy 8.1% -2.26%
OMCL Omnicell, Inc. Buy 8.22% -0.72%
ADMA ADMA Biologics, Inc. Buy 8.15% -1.63%
ABUS Arbutus Biopharma Corporation Buy 6.07% -3.33%
CUTR Cutera, Inc. Sell -3.71% 1.02%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.52% 6.03%
XNCR Xencor, Inc. Sell -3.62% 3.33%
ORGO Organogenesis Holdings Inc. Sell -3.25% 2.74%
SMTI Sanara MedTech Inc. Sell -5.63% 1.17%
The percentage of cash held in the portfolio is: 34.17%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -15.74%
Assets Rebalanced
None
2024-03-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 7.4% 6.04%
THC Tenet Healthcare Corporation Buy 8.37% 6.46%
MRSN Mersana Therapeutics, Inc. Buy 7.59% -3.37%
RDNT RadNet, Inc. Buy 7.98% 1.53%
NTRA Natera, Inc. Buy 7.82% -0.5%
QTRX Quanterix Corporation Buy 7.25% -6.27%
BHVN Biohaven Ltd. Buy 8.2% 5.96%
RGNX REGENXBIO Inc. Buy 8.14% 5.2%
BAX Baxter International Inc. Buy 8.02% -0.72%
OMCL Omnicell, Inc. Buy 8.07% -0.11%
ADMA ADMA Biologics, Inc. Buy 8.27% 2.29%
ABUS Arbutus Biopharma Corporation Buy 6.13% 0%
CUTR Cutera, Inc. Sell -3.68% -0.51%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.55% 3%
XNCR Xencor, Inc. Sell -3.75% -2.5%
ORGO Organogenesis Holdings Inc. Sell -3.35% -2.74%
SMTI Sanara MedTech Inc. Sell -5.63% -1.39%
The percentage of cash held in the portfolio is: 26.71%
New Assets Added
None
Assets Removed
Asset Action Perf %
TDOC Buy All 3.2%
Assets Rebalanced
None
2024-03-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 7.31% 4.88%
THC Tenet Healthcare Corporation Buy 8.32% 6.01%
MRSN Mersana Therapeutics, Inc. Buy 7.45% -5.05%
RDNT RadNet, Inc. Buy 8.14% 3.77%
NTRA Natera, Inc. Buy 7.97% 1.57%
QTRX Quanterix Corporation Buy 7.38% -4.49%
BHVN Biohaven Ltd. Buy 8.02% 3.88%
RGNX REGENXBIO Inc. Buy 7.95% 2.9%
BAX Baxter International Inc. Buy 8.05% -0.23%
OMCL Omnicell, Inc. Buy 8.15% 1.04%
ADMA ADMA Biologics, Inc. Buy 8.2% 1.63%
ABUS Arbutus Biopharma Corporation Buy 6.09% -0.37%
TDOC Teladoc Health, Inc. Sell -3.67% 1.73%
CUTR Cutera, Inc. Sell -3.74% -2.54%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.4% 6.79%
XNCR Xencor, Inc. Sell -3.65% -0.04%
ORGO Organogenesis Holdings Inc. Sell -3.28% -0.68%
SMTI Sanara MedTech Inc. Sell -5.56% -0.16%
The percentage of cash held in the portfolio is: 30.28%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Sell All -5.28%
APLS Sell All -9.48%
TVTX Sell All -9.99%
Assets Rebalanced
None
2024-03-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 7.35% 5.76%
THC Tenet Healthcare Corporation Buy 8.05% 2.95%
MRSN Mersana Therapeutics, Inc. Buy 7.49% -4.21%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.68% -1.76%
RDNT RadNet, Inc. Buy 8.15% 4.24%
NTRA Natera, Inc. Buy 7.81% -0.15%
QTRX Quanterix Corporation Buy 7.23% -6.13%
BHVN Biohaven Ltd. Buy 7.56% -1.79%
RGNX REGENXBIO Inc. Buy 8.24% 6.98%
APLS Apellis Pharmaceuticals, Inc. Buy 7.23% -6.1%
BAX Baxter International Inc. Buy 8.13% 1.14%
OMCL Omnicell, Inc. Buy 8.18% 1.76%
ADMA ADMA Biologics, Inc. Buy 8.12% 0.98%
TVTX Travere Therapeutics, Inc. Buy 7.46% -7.2%
ABUS Arbutus Biopharma Corporation Buy 6.14% 0.74%
TDOC Teladoc Health, Inc. Sell -3.71% 0.32%
CUTR Cutera, Inc. Sell -3.73% -2.54%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.46% 4.93%
XNCR Xencor, Inc. Sell -3.69% -1.49%
ORGO Organogenesis Holdings Inc. Sell -3.31% -2.05%
SMTI Sanara MedTech Inc. Sell -5.49% 0.79%
The percentage of cash held in the portfolio is: 8.57%
New Assets Added
None
Assets Removed
Asset Action Perf %
INO Buy All -33.33%
ACRS Sell All 3.2%
Assets Rebalanced
None
2024-03-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 7.17% 6.46%
THC Tenet Healthcare Corporation Buy 7.94% 4.66%
MRSN Mersana Therapeutics, Inc. Buy 7.38% -2.69%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.61% 0.33%
RDNT RadNet, Inc. Buy 7.95% 4.87%
NTRA Natera, Inc. Buy 7.55% -0.39%
QTRX Quanterix Corporation Buy 7.06% -5.45%
BHVN Biohaven Ltd. Buy 7.68% 2.8%
RGNX REGENXBIO Inc. Buy 7.95% 6.51%
ACRS Aclaris Therapeutics, Inc. Buy 8.42% 12.8%
APLS Apellis Pharmaceuticals, Inc. Buy 7.12% -4.64%
BAX Baxter International Inc. Buy 7.94% 1.81%
OMCL Omnicell, Inc. Buy 8.01% 2.73%
ADMA ADMA Biologics, Inc. Buy 8.08% 3.59%
TVTX Travere Therapeutics, Inc. Buy 7.84% 0.58%
ABUS Arbutus Biopharma Corporation Buy 5.98% 1.11%
TDOC Teladoc Health, Inc. Sell -3.56% 1.41%
CUTR Cutera, Inc. Sell -3.55% -0.51%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.39% 4%
XNCR Xencor, Inc. Sell -3.76% -6.41%
ORGO Organogenesis Holdings Inc. Sell -3.35% -6.51%
SMTI Sanara MedTech Inc. Sell -5.32% 0.73%
INO Inovio Pharmaceuticals, Inc. Sell -3.4% -12.74%
The percentage of cash held in the portfolio is: 4.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
SAGE Buy All 5.07%
CERS Sell All -6.61%
Assets Rebalanced
None
2024-03-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 7.19% 8.46%
THC Tenet Healthcare Corporation Buy 7.77% 4.1%
MRSN Mersana Therapeutics, Inc. Buy 7.35% -1.52%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.64% 2.41%
RDNT RadNet, Inc. Buy 8.16% 9.45%
NTRA Natera, Inc. Buy 7.65% 2.52%
QTRX Quanterix Corporation Buy 7.34% -0.07%
BHVN Biohaven Ltd. Buy 7.56% 2.94%
RGNX REGENXBIO Inc. Buy 7.99% 8.75%
ACRS Aclaris Therapeutics, Inc. Buy 7.93% 8%
APLS Apellis Pharmaceuticals, Inc. Buy 7.09% -3.39%
BAX Baxter International Inc. Buy 7.76% 1.16%
OMCL Omnicell, Inc. Buy 7.74% 0.97%
ADMA ADMA Biologics, Inc. Buy 7.72% 0.65%
TVTX Travere Therapeutics, Inc. Buy 7.76% 1.16%
CERS Cerus Corporation Buy 7.54% -1.65%
ABUS Arbutus Biopharma Corporation Buy 5.82% 0%
SAGE Sage Therapeutics, Inc. Sell -4.46% 8.17%
TDOC Teladoc Health, Inc. Sell -3.48% 1.85%
CUTR Cutera, Inc. Sell -3.58% -3.05%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.29% 5.2%
XNCR Xencor, Inc. Sell -3.62% -4.39%
ORGO Organogenesis Holdings Inc. Sell -3.32% -7.19%
SMTI Sanara MedTech Inc. Sell -5.28% -0.11%
INO Inovio Pharmaceuticals, Inc. Sell -2.97% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • INO
  • ABUS
Assets Removed
Asset Action Perf %
AORT Buy All -2.88%
RCM Sell All 27.04%
Assets Rebalanced
None
2024-03-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 6.25% 24.71%
PTGX Protagonist Therapeutics, Inc. Buy 7.24% 9.8%
THC Tenet Healthcare Corporation Buy 7.66% 3.23%
MRSN Mersana Therapeutics, Inc. Buy 7.17% -3.37%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.57% 2.02%
RDNT RadNet, Inc. Buy 8.11% 9.36%
NTRA Natera, Inc. Buy 7.48% 0.91%
QTRX Quanterix Corporation Buy 7.36% 0.75%
BHVN Biohaven Ltd. Buy 7.53% 3.09%
RGNX REGENXBIO Inc. Buy 8.21% 12.36%
ACRS Aclaris Therapeutics, Inc. Buy 8.41% 15.2%
APLS Apellis Pharmaceuticals, Inc. Buy 6.89% -5.71%
BAX Baxter International Inc. Buy 7.63% 0%
OMCL Omnicell, Inc. Buy 7.63% 0%
ADMA ADMA Biologics, Inc. Buy 7.63% 0%
TVTX Travere Therapeutics, Inc. Buy 7.63% 0%
CERS Cerus Corporation Buy 7.63% 0%
SAGE Sage Therapeutics, Inc. Sell -4.38% 9.2%
TDOC Teladoc Health, Inc. Sell -3.29% 6.78%
CUTR Cutera, Inc. Sell -3.7% -7.11%
AORT Artivion, Inc. Sell -3.47% -0.47%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.3% 4.34%
XNCR Xencor, Inc. Sell -3.61% -4.56%
ORGO Organogenesis Holdings Inc. Sell -3% 2.4%
SMTI Sanara MedTech Inc. Sell -5.24% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • BAX
  • OMCL
  • ADMA
  • TVTX
  • CERS
Assets Removed
Asset Action Perf %
BRKR Sell All 13.09%
NUTX Sell All -12.3%
Assets Rebalanced
None
2024-03-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 7.32% 12.64%
NUTX Nutex Health Inc. Buy 6.98% -11.48%
RCM R1 RCM Inc. Buy 6.33% 25.07%
PTGX Protagonist Therapeutics, Inc. Buy 7.23% 8.71%
THC Tenet Healthcare Corporation Buy 7.59% 1.35%
MRSN Mersana Therapeutics, Inc. Buy 7.27% -2.86%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.35% -1.89%
RDNT RadNet, Inc. Buy 8.01% 6.94%
NTRA Natera, Inc. Buy 7.34% -2%
QTRX Quanterix Corporation Buy 7.41% 0.5%
BHVN Biohaven Ltd. Buy 7.67% 4.01%
RGNX REGENXBIO Inc. Buy 8.49% 15.22%
ACRS Aclaris Therapeutics, Inc. Buy 7.49% 1.6%
APLS Apellis Pharmaceuticals, Inc. Buy 7.13% -3.34%
SAGE Sage Therapeutics, Inc. Sell -4.44% 8.77%
TDOC Teladoc Health, Inc. Sell -3.28% 7.99%
CUTR Cutera, Inc. Sell -3.68% -5.58%
AORT Artivion, Inc. Sell -3.4% 2.57%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.31% 5.1%
XNCR Xencor, Inc. Sell -3.49% -0.26%
ORGO Organogenesis Holdings Inc. Sell -2.96% 4.79%
The percentage of cash held in the portfolio is: 20.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
GKOS Buy All 9.9%
Assets Rebalanced
None
2024-03-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BRKR Bruker Corporation Buy 7.42% 12.49%
NUTX Nutex Health Inc. Buy 7.48% -6.56%
RCM R1 RCM Inc. Buy 6.44% 25.25%
PTGX Protagonist Therapeutics, Inc. Buy 7.51% 11.13%
THC Tenet Healthcare Corporation Buy 7.56% -0.63%
MRSN Mersana Therapeutics, Inc. Buy 7.36% -3.2%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.75% 1.95%
RDNT RadNet, Inc. Buy 8.03% 5.61%
NTRA Natera, Inc. Buy 7.67% 0.89%
QTRX Quanterix Corporation Buy 7.49% 0%
BHVN Biohaven Ltd. Buy 7.49% 0%
RGNX REGENXBIO Inc. Buy 7.49% 0%
ACRS Aclaris Therapeutics, Inc. Buy 7.49% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 7.49% 0%
GKOS Glaukos Corporation Sell -3.33% 5.35%
SAGE Sage Therapeutics, Inc. Sell -4.63% 6.45%
TDOC Teladoc Health, Inc. Sell -3.41% 5.82%
CUTR Cutera, Inc. Sell -3.86% -9.14%
AORT Artivion, Inc. Sell -3.56% -0.58%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.5% 1.1%
XNCR Xencor, Inc. Sell -3.72% -4.96%
ORGO Organogenesis Holdings Inc. Sell -3.11% 1.37%
The percentage of cash held in the portfolio is: 24.46%
New Assets Added
  • QTRX
  • BHVN
  • RGNX
  • ACRS
  • APLS
Assets Removed
Asset Action Perf %
OMI Sell All 15.7%
RVNC Sell All -14.99%
Assets Rebalanced
None
2024-03-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMI Owens & Minor, Inc. Buy 7.66% 14.13%
BRKR Bruker Corporation Buy 7.31% 10.34%
NUTX Nutex Health Inc. Buy 7.44% -7.38%
RCM R1 RCM Inc. Buy 6.47% 25.34%
PTGX Protagonist Therapeutics, Inc. Buy 7.65% 12.89%
RVNC Revance Therapeutics, Inc. Buy 7.54% -2.24%
THC Tenet Healthcare Corporation Buy 7.63% 0%
MRSN Mersana Therapeutics, Inc. Buy 7.63% 0%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.63% 0%
RDNT RadNet, Inc. Buy 7.63% 0%
NTRA Natera, Inc. Buy 7.63% 0%
GKOS Glaukos Corporation Sell -3.35% 5.08%
SAGE Sage Therapeutics, Inc. Sell -4.66% 6.06%
TDOC Teladoc Health, Inc. Sell -3.48% 4.09%
CUTR Cutera, Inc. Sell -4.35% -22.34%
AORT Artivion, Inc. Sell -3.54% 0.26%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.74% -5.17%
XNCR Xencor, Inc. Sell -3.71% -4.52%
ORGO Organogenesis Holdings Inc. Sell -3.16% 0%
The percentage of cash held in the portfolio is: 47.78%
New Assets Added
  • ORGO
  • THC
  • MRSN
  • ENTA
  • RDNT
  • NTRA
Assets Removed
Asset Action Perf %
HAE Buy All 0.05%
FATE Sell All 23.05%
CHRS Sell All -8.02%
Assets Rebalanced
None
2024-03-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 7.86% 12.72%
CHRS Coherus BioSciences, Inc. Buy 6.15% -12.98%
OMI Owens & Minor, Inc. Buy 7.63% 12.69%
BRKR Bruker Corporation Buy 7.22% 8.11%
NUTX Nutex Health Inc. Buy 7.5% -7.38%
RCM R1 RCM Inc. Buy 6.55% 25.78%
PTGX Protagonist Therapeutics, Inc. Buy 7.29% 6.67%
RVNC Revance Therapeutics, Inc. Buy 7.78% 0%
HAE Haemonetics Corporation Sell -4.09% 1.64%
GKOS Glaukos Corporation Sell -3.37% 5.32%
SAGE Sage Therapeutics, Inc. Sell -4.62% 7.69%
TDOC Teladoc Health, Inc. Sell -3.53% 3.58%
CUTR Cutera, Inc. Sell -4.07% -13.71%
AORT Artivion, Inc. Sell -3.63% -1.21%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.62% -0.93%
XNCR Xencor, Inc. Sell -3.61% -0.7%
The percentage of cash held in the portfolio is: 72.55%
New Assets Added
  • RVNC
Assets Removed
Asset Action Perf %
CARA Sell All 32.4%
NVAX Sell All 14.88%
VRDN Sell All -7.24%
CERS Sell All -5.22%
Assets Rebalanced
None
2024-02-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Buy 6.77% -4.35%
FATE Fate Therapeutics, Inc. Buy 7.83% 13.51%
CHRS Coherus BioSciences, Inc. Buy 6.3% -9.92%
OMI Owens & Minor, Inc. Buy 7.77% 15.98%
BRKR Bruker Corporation Buy 7.13% 8.03%
NUTX Nutex Health Inc. Buy 7.35% -8.2%
RCM R1 RCM Inc. Buy 6.63% 28.83%
NVAX Novavax, Inc. Buy 5.62% 2.56%
CARA Cara Therapeutics, Inc. Buy 7.79% 38.63%
PTGX Protagonist Therapeutics, Inc. Buy 7.22% 6.85%
VRDN Viridian Therapeutics, Inc. Buy 8.23% 0%
HAE Haemonetics Corporation Sell -4.15% -0.9%
GKOS Glaukos Corporation Sell -3.39% 3.77%
SAGE Sage Therapeutics, Inc. Sell -4.8% 3.09%
TDOC Teladoc Health, Inc. Sell -3.5% 3.52%
CUTR Cutera, Inc. Sell -3.54% 0%
AORT Artivion, Inc. Sell -3.54% 0%
RCKT Rocket Pharmaceuticals, Inc. Sell -3.54% 0%
XNCR Xencor, Inc. Sell -3.54% 0%
The percentage of cash held in the portfolio is: 51.36%
New Assets Added
  • CUTR
  • AORT
  • RCKT
  • XNCR
  • VRDN
Assets Removed
Asset Action Perf %
CTLT Buy All -2.55%
MCRB Buy All -12.75%
ACRS Sell All -3.25%
CUTR Sell All -32.07%
RGNX Sell All 36.58%
MYGN Sell All -8.39%
INGN Sell All -38.03%
Assets Rebalanced
None
2024-02-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 7.66% 37.41%
CERS Cerus Corporation Buy 6.47% -0.87%
FATE Fate Therapeutics, Inc. Buy 7.55% 18.6%
ACRS Aclaris Therapeutics, Inc. Buy 6.29% -2.44%
CHRS Coherus BioSciences, Inc. Buy 6.45% 0%
OMI Owens & Minor, Inc. Buy 7.09% 14.73%
BRKR Bruker Corporation Buy 6.37% 4.56%
NUTX Nutex Health Inc. Buy 6.79% -8.2%
CUTR Cutera, Inc. Buy 7.2% -8.97%
MYGN Myriad Genetics, Inc. Buy 6.93% -0.38%
INGN Inogen, Inc. Buy 6.4% -7.98%
RCM R1 RCM Inc. Buy 6.2% 30.53%
NVAX Novavax, Inc. Buy 7.08% 40%
CARA Cara Therapeutics, Inc. Buy 7.64% 47.35%
PTGX Protagonist Therapeutics, Inc. Buy 6.48% 3.9%
CTLT Catalent, Inc. Sell -4.12% -3.01%
MCRB Seres Therapeutics, Inc. Sell -4.47% -11.76%
HAE Haemonetics Corporation Sell -3.8% -0.11%
GKOS Glaukos Corporation Sell -3.14% 3.31%
SAGE Sage Therapeutics, Inc. Sell -4.46% 2.41%
TDOC Teladoc Health, Inc. Sell -3.24% 3.07%
The percentage of cash held in the portfolio is: 20.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATRI Sell All 0.86%
VKTX Sell All 194.39%
Assets Rebalanced
None
2024-02-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 6.64% 1.57%
RGNX REGENXBIO Inc. Buy 7.89% 25.88%
CERS Cerus Corporation Buy 7.06% -3.91%
VKTX Viking Therapeutics, Inc. Buy 6.61% 33.19%
FATE Fate Therapeutics, Inc. Buy 7.91% 10.49%
ACRS Aclaris Therapeutics, Inc. Buy 7.14% -1.63%
CHRS Coherus BioSciences, Inc. Buy 6.92% -4.58%
OMI Owens & Minor, Inc. Buy 7.62% 9.68%
BRKR Bruker Corporation Buy 7.16% 4.43%
NUTX Nutex Health Inc. Buy 7.63% -8.2%
CUTR Cutera, Inc. Buy 7.91% -11.03%
MYGN Myriad Genetics, Inc. Buy 7.6% -2.8%
INGN Inogen, Inc. Buy 7.15% -8.57%
RCM R1 RCM Inc. Buy 6.64% 24.35%
NVAX Novavax, Inc. Buy 7.28% 27.91%
CARA Cara Therapeutics, Inc. Buy 7.28% 24.77%
PTGX Protagonist Therapeutics, Inc. Buy 7.28% 3.69%
CTLT Catalent, Inc. Sell -4.64% -3.17%
MCRB Seres Therapeutics, Inc. Sell -4.72% -4.9%
HAE Haemonetics Corporation Sell -4.21% 1.33%
GKOS Glaukos Corporation Sell -3.58% 2.07%
SAGE Sage Therapeutics, Inc. Sell -5% 2.75%
TDOC Teladoc Health, Inc. Sell -3.56% 5.43%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVTA Buy All 87.43%
TVTX Buy All 2.91%
Assets Rebalanced
Asset Action Weight
VKTX Sell -1.06%
RCM Sell -1.65%
CARA Sell -1.03%
PTGX Sell -1.11%
NVAX Sell -2.72%
RGNX Buy 0.29%
NUTX Buy 0.62%
CUTR Buy 1.78%
2024-02-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 6.68% 0.57%
RGNX REGENXBIO Inc. Buy 6.74% 19.49%
VKTX Viking Therapeutics, Inc. Buy 7.58% 29.53%
CERS Cerus Corporation Buy 7.17% -3.91%
ACRS Aclaris Therapeutics, Inc. Buy 7.13% -3.25%
FATE Fate Therapeutics, Inc. Buy 8.05% 10.65%
CHRS Coherus BioSciences, Inc. Buy 7.25% -1.53%
OMI Owens & Minor, Inc. Buy 7.81% 10.61%
BRKR Bruker Corporation Buy 7.36% 5.77%
NUTX Nutex Health Inc. Buy 7.12% -3.28%
CUTR Cutera, Inc. Buy 5.79% -17.24%
NVAX Novavax, Inc. Buy 9.77% 23.02%
MYGN Myriad Genetics, Inc. Buy 7.65% -3.69%
INGN Inogen, Inc. Buy 7.19% -9.46%
RCM R1 RCM Inc. Buy 6.73% -0.63%
CARA Cara Therapeutics, Inc. Buy 9.56% 41.28%
PTGX Protagonist Therapeutics, Inc. Buy 8.21% 0%
NVTA Invitae Corporation Sell -0.49% 86.53%
TVTX Travere Therapeutics, Inc. Sell -3.47% 3.87%
CTLT Catalent, Inc. Sell -4.75% -4.02%
MCRB Seres Therapeutics, Inc. Sell -4.75% -3.92%
HAE Haemonetics Corporation Sell -4.29% 0.93%
GKOS Glaukos Corporation Sell -3.55% 4.27%
SAGE Sage Therapeutics, Inc. Sell -4.94% 5.41%
TDOC Teladoc Health, Inc. Sell -3.54% 7.29%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
NTLA Sell All 3.2%
Assets Rebalanced
None
2024-02-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 7.72% 7.47%
ATRI Atrion Corporation Buy 6.62% -2.34%
RGNX REGENXBIO Inc. Buy 7.18% 24.71%
VKTX Viking Therapeutics, Inc. Buy 7.38% 23.43%
CERS Cerus Corporation Buy 7.35% -3.48%
ACRS Aclaris Therapeutics, Inc. Buy 7.4% -1.63%
FATE Fate Therapeutics, Inc. Buy 8.12% 9.38%
CHRS Coherus BioSciences, Inc. Buy 7.09% -5.73%
OMI Owens & Minor, Inc. Buy 7.75% 7.46%
BRKR Bruker Corporation Buy 7.44% 4.61%
NUTX Nutex Health Inc. Buy 7.28% -3.28%
CUTR Cutera, Inc. Buy 6.5% -8.97%
NVAX Novavax, Inc. Buy 9.2% 13.49%
MYGN Myriad Genetics, Inc. Buy 7.94% -2.08%
INGN Inogen, Inc. Buy 7.49% -7.68%
RCM R1 RCM Inc. Buy 6.9% -0.27%
CARA Cara Therapeutics, Inc. Buy 8.6% 24.45%
NVTA Invitae Corporation Sell -0.56% 84.85%
TVTX Travere Therapeutics, Inc. Sell -3.51% 4.84%
CTLT Catalent, Inc. Sell -4.82% -3.36%
MCRB Seres Therapeutics, Inc. Sell -5.03% -7.84%
HAE Haemonetics Corporation Sell -4.46% -0.94%
GKOS Glaukos Corporation Sell -3.71% 2.25%
SAGE Sage Therapeutics, Inc. Sell -5.1% 4.38%
TDOC Teladoc Health, Inc. Sell -3.79% 2.75%
The percentage of cash held in the portfolio is: 3.01%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
FATE Buy 0.2%
2024-02-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 7.91% 6.29%
ATRI Atrion Corporation Buy 7.31% 4.18%
RGNX REGENXBIO Inc. Buy 7.53% 26.29%
CERS Cerus Corporation Buy 7.68% -2.61%
VKTX Viking Therapeutics, Inc. Buy 7.53% 21.77%
ACRS Aclaris Therapeutics, Inc. Buy 7.6% -2.44%
CHRS Coherus BioSciences, Inc. Buy 7.37% -5.34%
FATE Fate Therapeutics, Inc. Buy 7.53% 8.59%
OMI Owens & Minor, Inc. Buy 7.53% 0.93%
NUTX Nutex Health Inc. Buy 7.53% -3.28%
CUTR Cutera, Inc. Buy 6.91% -6.55%
BRKR Bruker Corporation Buy 7.53% 2.34%
MYGN Myriad Genetics, Inc. Buy 8.15% -2.88%
NVAX Novavax, Inc. Buy 7.77% -7.44%
INGN Inogen, Inc. Buy 7.76% -7.49%
RCM R1 RCM Inc. Buy 6.84% -4.39%
CARA Cara Therapeutics, Inc. Buy 7.53% 5.3%
NVTA Invitae Corporation Sell -0.64% 83.16%
TVTX Travere Therapeutics, Inc. Sell -3.64% 4.6%
CTLT Catalent, Inc. Sell -4.98% -3.08%
MCRB Seres Therapeutics, Inc. Sell -4.97% -2.94%
HAE Haemonetics Corporation Sell -4.52% 1.25%
GKOS Glaukos Corporation Sell -3.89% 0.83%
SAGE Sage Therapeutics, Inc. Sell -5.26% 4.6%
TDOC Teladoc Health, Inc. Sell -4.04% 0%
The percentage of cash held in the portfolio is: 3.94%
New Assets Added
  • TDOC
Assets Removed
Asset Action Perf %
EBS Buy All -64.24%
Assets Rebalanced
Asset Action Weight
RCM Sell -1.18%
CUTR Sell -1.48%
FATE Sell -0.93%
NUTX Sell -1.15%
BRKR Sell -1.65%
VKTX Sell -2.07%
RGNX Sell -2.35%
NTLA Buy 0.82%
CARA Buy 1.04%
OMI Buy 4.62%
2024-02-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 6.48% 7.35%
ATRI Atrion Corporation Buy 6.87% 2.22%
RGNX REGENXBIO Inc. Buy 9.53% 27.25%
VKTX Viking Therapeutics, Inc. Buy 9.34% 23.71%
CERS Cerus Corporation Buy 7.58% 0.43%
FATE Fate Therapeutics, Inc. Buy 8.37% 12.24%
CHRS Coherus BioSciences, Inc. Buy 7.37% -1.15%
ACRS Aclaris Therapeutics, Inc. Buy 7.33% -1.63%
OMI Owens & Minor, Inc. Buy 2.75% -0.23%
NUTX Nutex Health Inc. Buy 8.1% -5.74%
BRKR Bruker Corporation Buy 8.7% 1.31%
CUTR Cutera, Inc. Buy 8.68% 1.03%
RCM R1 RCM Inc. Buy 7.75% -3.58%
INGN Inogen, Inc. Buy 7.51% -6.5%
NVAX Novavax, Inc. Buy 7.72% -3.95%
MYGN Myriad Genetics, Inc. Buy 8.01% -0.38%
CARA Cara Therapeutics, Inc. Buy 5.9% 0%
EBS Emergent BioSolutions Inc. Sell -3.35% 7.88%
TVTX Travere Therapeutics, Inc. Sell -3.66% -0.24%
NVTA Invitae Corporation Sell -0.69% 81.14%
MCRB Seres Therapeutics, Inc. Sell -4.72% -1.96%
CTLT Catalent, Inc. Sell -4.75% -2.62%
HAE Haemonetics Corporation Sell -4.22% 3.73%
GKOS Glaukos Corporation Sell -3.7% 1.54%
SAGE Sage Therapeutics, Inc. Sell -5.03% 4.73%
The percentage of cash held in the portfolio is: 2.12%
New Assets Added
  • CARA
Assets Removed
Asset Action Perf %
MRSN Sell All -14.18%
Assets Rebalanced
None
2024-02-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 6.48% 9.69%
ATRI Atrion Corporation Buy 6.65% 1.11%
RGNX REGENXBIO Inc. Buy 9.47% 29.24%
MRSN Mersana Therapeutics, Inc. Buy 6.63% -10.17%
VKTX Viking Therapeutics, Inc. Buy 9.25% 25.3%
CERS Cerus Corporation Buy 7.58% 2.61%
FATE Fate Therapeutics, Inc. Buy 8.77% 20.19%
CHRS Coherus BioSciences, Inc. Buy 7.68% 5.34%
ACRS Aclaris Therapeutics, Inc. Buy 7.06% -3.25%
OMI Owens & Minor, Inc. Buy 2.65% -1.76%
NUTX Nutex Health Inc. Buy 8.41% 0%
BRKR Bruker Corporation Buy 8.59% 2.21%
CUTR Cutera, Inc. Buy 8.49% 1.03%
RCM R1 RCM Inc. Buy 7.65% -2.69%
INGN Inogen, Inc. Buy 7.77% -1.18%
NVAX Novavax, Inc. Buy 7.61% -3.26%
MYGN Myriad Genetics, Inc. Buy 7.75% -1.44%
EBS Emergent BioSolutions Inc. Sell -3.37% 5.45%
TVTX Travere Therapeutics, Inc. Sell -3.55% 0.73%
NVTA Invitae Corporation Sell -0.78% 78.11%
MCRB Seres Therapeutics, Inc. Sell -4.66% -2.94%
CTLT Catalent, Inc. Sell -4.66% -2.9%
HAE Haemonetics Corporation Sell -4.18% 2.48%
GKOS Glaukos Corporation Sell -3.64% 1%
SAGE Sage Therapeutics, Inc. Sell -5.17% 0%
The percentage of cash held in the portfolio is: 1.51%
New Assets Added
  • SAGE
Assets Removed
Asset Action Perf %
SGMO Buy All -31.43%
Assets Rebalanced
None
2024-02-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 6.66% 12.57%
ATRI Atrion Corporation Buy 6.68% 1.57%
RGNX REGENXBIO Inc. Buy 9.28% 26.63%
MRSN Mersana Therapeutics, Inc. Buy 6.71% -9.22%
VKTX Viking Therapeutics, Inc. Buy 8.14% 10.25%
CERS Cerus Corporation Buy 7.68% 3.91%
FATE Fate Therapeutics, Inc. Buy 8.21% 12.56%
CHRS Coherus BioSciences, Inc. Buy 7.94% 8.78%
ACRS Aclaris Therapeutics, Inc. Buy 7.3% 0%
OMI Owens & Minor, Inc. Buy 2.69% -0.46%
NUTX Nutex Health Inc. Buy 8.34% -0.82%
BRKR Bruker Corporation Buy 8.41% 0.06%
CUTR Cutera, Inc. Buy 8.5% 1.03%
RCM R1 RCM Inc. Buy 7.87% 0%
INGN Inogen, Inc. Buy 7.87% 0%
NVAX Novavax, Inc. Buy 7.87% 0%
MYGN Myriad Genetics, Inc. Buy 7.87% 0%
EBS Emergent BioSolutions Inc. Sell -3.67% -3.03%
TVTX Travere Therapeutics, Inc. Sell -3.78% -5.81%
NVTA Invitae Corporation Sell -0.73% 79.46%
MCRB Seres Therapeutics, Inc. Sell -4.97% -9.8%
CTLT Catalent, Inc. Sell -4.6% -1.66%
HAE Haemonetics Corporation Sell -4.16% 3.13%
GKOS Glaukos Corporation Sell -3.78% -2.71%
SGMO Sangamo Therapeutics, Inc. Sell -4.31% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SGMO
  • RCM
  • INGN
  • NVAX
  • MYGN
Assets Removed
Asset Action Perf %
SMTI Buy All -13.95%
AGEN Sell All -7.14%
Assets Rebalanced
None
2024-02-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 6.56% 11.82%
ATRI Atrion Corporation Buy 6.3% -3.57%
AGEN Agenus Inc. Buy 8.66% 32.56%
RGNX REGENXBIO Inc. Buy 8.39% 15.24%
MRSN Mersana Therapeutics, Inc. Buy 6.57% -10.4%
VKTX Viking Therapeutics, Inc. Buy 8.18% 11.56%
CERS Cerus Corporation Buy 7.43% 1.3%
FATE Fate Therapeutics, Inc. Buy 7.48% 3.18%
CHRS Coherus BioSciences, Inc. Buy 7.52% 3.82%
ACRS Aclaris Therapeutics, Inc. Buy 7.19% -0.81%
OMI Owens & Minor, Inc. Buy 2.67% -0.42%
NUTX Nutex Health Inc. Buy 8.35% 0%
BRKR Bruker Corporation Buy 8.35% 0%
CUTR Cutera, Inc. Buy 8.35% 0%
EBS Emergent BioSolutions Inc. Sell -3.63% -2.42%
TVTX Travere Therapeutics, Inc. Sell -3.54% 0.12%
NVTA Invitae Corporation Sell -0.76% 78.68%
MCRB Seres Therapeutics, Inc. Sell -4.85% -7.84%
CTLT Catalent, Inc. Sell -4.53% -0.78%
HAE Haemonetics Corporation Sell -4.09% 3.99%
SMTI Sanara MedTech Inc. Sell -3.97% -8.63%
GKOS Glaukos Corporation Sell -3.7% -1.24%
The percentage of cash held in the portfolio is: 27.05%
New Assets Added
  • NUTX
  • BRKR
  • CUTR
Assets Removed
Asset Action Perf %
LXRX Sell All 55.87%
Assets Rebalanced
None
2024-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 8.47% 37.56%
NTLA Intellia Therapeutics, Inc. Buy 6.44% 4.59%
ATRI Atrion Corporation Buy 6.71% -2.04%
AGEN Agenus Inc. Buy 7.44% 8.57%
RGNX REGENXBIO Inc. Buy 8.4% 10.09%
MRSN Mersana Therapeutics, Inc. Buy 6.97% -9.46%
VKTX Viking Therapeutics, Inc. Buy 8.15% 5.92%
CERS Cerus Corporation Buy 7.26% -5.65%
FATE Fate Therapeutics, Inc. Buy 7.72% 1.59%
CHRS Coherus BioSciences, Inc. Buy 7.43% -2.29%
ACRS Aclaris Therapeutics, Inc. Buy 7.23% -4.88%
OMI Owens & Minor, Inc. Buy 2.75% -2.32%
EBS Emergent BioSolutions Inc. Sell -3.58% 3.64%
TVTX Travere Therapeutics, Inc. Sell -3.6% 3.27%
NVTA Invitae Corporation Sell -1.25% 66.33%
MCRB Seres Therapeutics, Inc. Sell -4.9% -3.92%
CTLT Catalent, Inc. Sell -4.69% 0.46%
HAE Haemonetics Corporation Sell -4.32% 3.37%
SMTI Sanara MedTech Inc. Sell -3.83% 0%
GKOS Glaukos Corporation Sell -3.83% 0%
The percentage of cash held in the portfolio is: 45.04%
New Assets Added
  • SMTI
  • GKOS
Assets Removed
Asset Action Perf %
ARCT Sell All 2.7%
DCPH Sell All -7.82%
SAVA Sell All -6.26%
SMTI Sell All -9.09%
CLDX Sell All -6.72%
Assets Rebalanced
None
2024-02-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 7.94% 37.09%
NTLA Intellia Therapeutics, Inc. Buy 6.78% 17.08%
ATRI Atrion Corporation Buy 7.2% 11.82%
ARCT Arcturus Therapeutics Holdings Inc. Buy 7.1% 10.25%
AGEN Agenus Inc. Buy 7.45% 15.71%
SMTI Sanara MedTech Inc. Buy 7.04% -1.84%
RGNX REGENXBIO Inc. Buy 8.55% 19.15%
CLDX Celldex Therapeutics, Inc. Buy 7.13% -0.58%
SAVA Cassava Sciences, Inc. Buy 7.04% -1.93%
MRSN Mersana Therapeutics, Inc. Buy 6.72% -7.09%
VKTX Viking Therapeutics, Inc. Buy 7.94% 9.81%
CERS Cerus Corporation Buy 7.45% 3.04%
FATE Fate Therapeutics, Inc. Buy 7.79% 9.06%
CHRS Coherus BioSciences, Inc. Buy 7.69% 7.63%
ACRS Aclaris Therapeutics, Inc. Buy 7.15% 0%
DCPH Deciphera Pharmaceuticals, Inc. Buy 7.08% -0.95%
OMI Owens & Minor, Inc. Buy 2.65% 0%
EBS Emergent BioSolutions Inc. Sell -3.81% -9.09%
TVTX Travere Therapeutics, Inc. Sell -3.75% -7.26%
NVTA Invitae Corporation Sell -1.45% 58.47%
MCRB Seres Therapeutics, Inc. Sell -5% -12.75%
CTLT Catalent, Inc. Sell -4.47% -0.87%
HAE Haemonetics Corporation Sell -4.23% -0.77%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OMI
Assets Removed
Asset Action Perf %
CUTR Buy All -27.2%
Assets Rebalanced
None
2024-02-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.66% 12.21%
NTLA Intellia Therapeutics, Inc. Buy 6.62% 11.63%
ATRI Atrion Corporation Buy 7.19% 8.91%
ARCT Arcturus Therapeutics Holdings Inc. Buy 6.93% 5.01%
AGEN Agenus Inc. Buy 7.07% 7.14%
SMTI Sanara MedTech Inc. Buy 7.52% 2.2%
RGNX REGENXBIO Inc. Buy 8.18% 11.26%
CLDX Celldex Therapeutics, Inc. Buy 7.4% 0.61%
SAVA Cassava Sciences, Inc. Buy 7.26% -1.34%
MRSN Mersana Therapeutics, Inc. Buy 6.8% -8.27%
VKTX Viking Therapeutics, Inc. Buy 7.85% 5.85%
CERS Cerus Corporation Buy 7.61% 2.61%
FATE Fate Therapeutics, Inc. Buy 7.32% 0%
CHRS Coherus BioSciences, Inc. Buy 7.32% 0%
ACRS Aclaris Therapeutics, Inc. Buy 7.32% 0%
DCPH Deciphera Pharmaceuticals, Inc. Buy 7.32% 0%
EBS Emergent BioSolutions Inc. Sell -3.43% 4.24%
CUTR Cutera, Inc. Sell -3.93% -9.62%
TVTX Travere Therapeutics, Inc. Sell -3.68% -2.66%
NVTA Invitae Corporation Sell -0.8% 77.55%
MCRB Seres Therapeutics, Inc. Sell -4.99% -9.8%
CTLT Catalent, Inc. Sell -4.56% -0.37%
HAE Haemonetics Corporation Sell -4.31% 0%
The percentage of cash held in the portfolio is: 9.32%
New Assets Added
  • HAE
  • FATE
  • CHRS
  • ACRS
  • DCPH
Assets Removed
Asset Action Perf %
CARA Buy All -8.85%
Assets Rebalanced
None
2024-02-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.45% 7.98%
NTLA Intellia Therapeutics, Inc. Buy 6.48% 8.62%
ATRI Atrion Corporation Buy 7.02% 5.75%
ARCT Arcturus Therapeutics Holdings Inc. Buy 6.67% 0.42%
AGEN Agenus Inc. Buy 6.64% 0%
SMTI Sanara MedTech Inc. Buy 7.7% 4.06%
RGNX REGENXBIO Inc. Buy 8.27% 11.81%
CLDX Celldex Therapeutics, Inc. Buy 7.34% -0.77%
SAVA Cassava Sciences, Inc. Buy 7.36% -0.59%
MRSN Mersana Therapeutics, Inc. Buy 7.46% 0%
VKTX Viking Therapeutics, Inc. Buy 7.46% 0%
CERS Cerus Corporation Buy 7.46% 0%
EBS Emergent BioSolutions Inc. Sell -3.66% -1.82%
CUTR Cutera, Inc. Sell -4% -10.88%
TVTX Travere Therapeutics, Inc. Sell -3.63% -0.48%
NVTA Invitae Corporation Sell -0.73% 79.8%
MCRB Seres Therapeutics, Inc. Sell -4.64% -1.47%
CTLT Catalent, Inc. Sell -4.57% -0.09%
CARA Cara Therapeutics, Inc. Sell -4.38% 0%
The percentage of cash held in the portfolio is: 39.3%
New Assets Added
  • CARA
  • MRSN
  • VKTX
  • CERS
Assets Removed
Asset Action Perf %
PAHC Buy All -7.81%
Assets Rebalanced
None
2024-02-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.14% 0.94%
NTLA Intellia Therapeutics, Inc. Buy 6.27% 3.08%
ATRI Atrion Corporation Buy 7.15% 5.59%
ARCT Arcturus Therapeutics Holdings Inc. Buy 6.69% -1.19%
AGEN Agenus Inc. Buy 6.58% -2.86%
SMTI Sanara MedTech Inc. Buy 7.54% 0%
RGNX REGENXBIO Inc. Buy 7.54% 0%
CLDX Celldex Therapeutics, Inc. Buy 7.54% 0%
SAVA Cassava Sciences, Inc. Buy 7.54% 0%
EBS Emergent BioSolutions Inc. Sell -3.33% 9.09%
PAHC Phibro Animal Health Corporation Sell -3.68% -0.38%
CUTR Cutera, Inc. Sell -4.29% -16.74%
TVTX Travere Therapeutics, Inc. Sell -3.69% -0.24%
NVTA Invitae Corporation Sell -1.03% 71.94%
MCRB Seres Therapeutics, Inc. Sell -4.66% 0%
CTLT Catalent, Inc. Sell -4.66% 0%
The percentage of cash held in the portfolio is: 62.34%
New Assets Added
  • MCRB
  • CTLT
  • SMTI
  • RGNX
  • CLDX
  • SAVA
Assets Removed
None
Assets Rebalanced
None
2024-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.49% 3.76%
NTLA Intellia Therapeutics, Inc. Buy 6.58% 5.06%
ATRI Atrion Corporation Buy 6.97% 0%
ARCT Arcturus Therapeutics Holdings Inc. Buy 6.97% 0%
AGEN Agenus Inc. Buy 6.97% 0%
EBS Emergent BioSolutions Inc. Sell -3.57% 5.45%
PAHC Phibro Animal Health Corporation Sell -3.84% -1.79%
CUTR Cutera, Inc. Sell -4.4% -16.32%
TVTX Travere Therapeutics, Inc. Sell -3.97% -4.96%
NVTA Invitae Corporation Sell -3.78% 0.11%
The percentage of cash held in the portfolio is: 85.59%
New Assets Added
  • ATRI
  • ARCT
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.02% -3.76%
NTLA Intellia Therapeutics, Inc. Buy 6.15% -1.78%
EBS Emergent BioSolutions Inc. Sell -3.5% 7.27%
PAHC Phibro Animal Health Corporation Sell -3.8% -0.85%
CUTR Cutera, Inc. Sell -3.78% 0%
TVTX Travere Therapeutics, Inc. Sell -3.78% 0%
NVTA Invitae Corporation Sell -3.78% 0%
The percentage of cash held in the portfolio is: 106.48%
New Assets Added
  • CUTR
  • TVTX
  • NVTA
Assets Removed
Asset Action Perf %
PTGX Sell All -8.8%
Assets Rebalanced
None
2024-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 5.58% -7.12%
LXRX Lexicon Pharmaceuticals, Inc. Buy 6.24% 0%
NTLA Intellia Therapeutics, Inc. Buy 6.24% 0%
EBS Emergent BioSolutions Inc. Sell -3.7% 1.82%
PAHC Phibro Animal Health Corporation Sell -3.76% 0%
The percentage of cash held in the portfolio is: 89.39%
New Assets Added
  • PAHC
  • LXRX
  • NTLA
Assets Removed
None
Assets Rebalanced
None
2024-02-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 5.99% 0%
EBS Emergent BioSolutions Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 97.76%
New Assets Added
  • EBS
  • PTGX
Assets Removed
None
Assets Rebalanced
None
2023-12-11 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 4.11%
Assets Rebalanced
None
2023-12-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
STAA STAAR Surgical Company Sell -3.08% 10.08%
The percentage of cash held in the portfolio is: 103.08%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMRX Buy All -7.32%
MRSN Sell All 32.47%
Assets Rebalanced
None
2023-12-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
MRSN Mersana Therapeutics, Inc. Buy 8.93% 38.31%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.6% -5.72%
STAA STAAR Surgical Company Sell -3.01% 11.57%
The percentage of cash held in the portfolio is: 97.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGRY Sell All 12.06%
AMEH Sell All -1.35%
VKTX Sell All 55.42%
KIDS Sell All -1.71%
QTRX Sell All 4.15%
NVCR Sell All -0.23%
Assets Rebalanced
None
2023-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGRY Surgery Partners, Inc. Buy 7.07% 17.66%
AMEH Apollo Medical Holdings, Inc. Buy 6.3% 2.23%
VKTX Viking Therapeutics, Inc. Buy 8.46% 35%
KIDS OrthoPediatrics Corp. Buy 6.05% 0.67%
QTRX Quanterix Corporation Buy 7.65% 8.74%
NVCR NovoCure Limited Buy 7.41% 1.48%
MRSN Mersana Therapeutics, Inc. Buy 8.62% 32.47%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.7% -7.78%
STAA STAAR Surgical Company Sell -3.18% 7.29%
The percentage of cash held in the portfolio is: 55.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
CBAY Sell All 20.69%
SENS Sell All 18.74%
Assets Rebalanced
None
2023-11-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
CBAY CymaBay Therapeutics, Inc. Buy 6.54% 6.88%
SENS Senseonics Holdings, Inc. Buy 6.35% 4.68%
SGRY Surgery Partners, Inc. Buy 6.83% 6.13%
AMEH Apollo Medical Holdings, Inc. Buy 6.51% -1.26%
VKTX Viking Therapeutics, Inc. Buy 7.04% 4.92%
KIDS OrthoPediatrics Corp. Buy 6.78% 5.42%
QTRX Quanterix Corporation Buy 7.89% 4.77%
NVCR NovoCure Limited Buy 7.45% -4.69%
MRSN Mersana Therapeutics, Inc. Buy 6.92% -0.65%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.56% 2.97%
STAA STAAR Surgical Company Sell -3.37% 8.21%
The percentage of cash held in the portfolio is: 44.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACAD Buy All 5.15%
BMRN Sell All 2.66%
Assets Rebalanced
None
2023-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
BMRN BioMarin Pharmaceutical Inc. Buy 6.71% 3.64%
CBAY CymaBay Therapeutics, Inc. Buy 6.57% 7.88%
SENS Senseonics Holdings, Inc. Buy 6.48% 7.39%
SGRY Surgery Partners, Inc. Buy 6.84% 6.93%
AMEH Apollo Medical Holdings, Inc. Buy 6.55% -0.29%
VKTX Viking Therapeutics, Inc. Buy 7.17% 7.43%
KIDS OrthoPediatrics Corp. Buy 6.74% 5.25%
QTRX Quanterix Corporation Buy 7.95% 6.05%
NVCR NovoCure Limited Buy 7.23% -6.95%
MRSN Mersana Therapeutics, Inc. Buy 6.88% -0.65%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.53% 5.87%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.59% 1.83%
STAA STAAR Surgical Company Sell -3.34% 8.7%
The percentage of cash held in the portfolio is: 41.33%
New Assets Added
None
Assets Removed
Asset Action Perf %
MNKD Buy All 4.35%
NVAX Buy All 20.75%
LLY Sell All -0.61%
Assets Rebalanced
None
2023-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
LLY Eli Lilly and Company Buy 6.68% 0.99%
BMRN BioMarin Pharmaceutical Inc. Buy 6.62% 3.16%
CBAY CymaBay Therapeutics, Inc. Buy 6.83% 13.22%
SENS Senseonics Holdings, Inc. Buy 6.37% 6.49%
SGRY Surgery Partners, Inc. Buy 6.89% 8.52%
AMEH Apollo Medical Holdings, Inc. Buy 6.57% 0.88%
VKTX Viking Therapeutics, Inc. Buy 7.28% 9.94%
KIDS OrthoPediatrics Corp. Buy 6.68% 5.25%
QTRX Quanterix Corporation Buy 8.03% 8.12%
NVCR NovoCure Limited Buy 7.51% -2.58%
MRSN Mersana Therapeutics, Inc. Buy 7.09% 3.25%
MNKD MannKind Corporation Sell -3.63% 1.63%
NVAX Novavax, Inc. Sell -2.98% 19.16%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.53% 5.15%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.75% -3.43%
STAA STAAR Surgical Company Sell -3.53% 2.67%
The percentage of cash held in the portfolio is: 40.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMN Buy All -0.43%
Assets Rebalanced
None
2023-11-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
LLY Eli Lilly and Company Buy 6.72% -0.02%
BMRN BioMarin Pharmaceutical Inc. Buy 6.75% 3.43%
CBAY CymaBay Therapeutics, Inc. Buy 6.52% 6.11%
SENS Senseonics Holdings, Inc. Buy 6.48% 6.49%
SGRY Surgery Partners, Inc. Buy 7.03% 8.81%
AMEH Apollo Medical Holdings, Inc. Buy 6.49% -1.96%
VKTX Viking Therapeutics, Inc. Buy 6.97% 3.49%
KIDS OrthoPediatrics Corp. Buy 6.86% 6.25%
QTRX Quanterix Corporation Buy 8.06% 6.66%
NVCR NovoCure Limited Buy 7.3% -6.88%
MRSN Mersana Therapeutics, Inc. Buy 6.79% -2.92%
AMN AMN Healthcare Services, Inc. Sell -3.76% -0.98%
MNKD MannKind Corporation Sell -3.72% 0.82%
NVAX Novavax, Inc. Sell -2.94% 21.63%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.54% 6.43%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.75% -1.83%
STAA STAAR Surgical Company Sell -3.57% 3.22%
The percentage of cash held in the portfolio is: 45.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
THC Sell All NA
ISRG Sell All NA
A Sell All NA
NEOG Sell All NA
RMD Sell All NA
Assets Rebalanced
None
2023-11-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 7.68% 25.52%
ISRG Intuitive Surgical, Inc. Buy 7.16% 13.64%
A Agilent Technologies, Inc. Buy 7.36% 18.68%
NEOG Neogen Corporation Buy 7.84% 8.1%
RMD ResMed Inc. Buy 6.67% 1.67%
LLY Eli Lilly and Company Buy 6.72% -0.02%
BMRN BioMarin Pharmaceutical Inc. Buy 6.75% 3.43%
CBAY CymaBay Therapeutics, Inc. Buy 6.52% 6.11%
SENS Senseonics Holdings, Inc. Buy 6.48% 6.49%
SGRY Surgery Partners, Inc. Buy 7.03% 8.81%
AMEH Apollo Medical Holdings, Inc. Buy 6.49% -1.96%
VKTX Viking Therapeutics, Inc. Buy 6.97% 3.49%
KIDS OrthoPediatrics Corp. Buy 6.86% 6.25%
QTRX Quanterix Corporation Buy 8.06% 6.66%
NVCR NovoCure Limited Buy 7.3% -6.88%
MRSN Mersana Therapeutics, Inc. Buy 6.79% -2.92%
AMN AMN Healthcare Services, Inc. Sell -3.76% -0.98%
MNKD MannKind Corporation Sell -3.72% 0.82%
NVAX Novavax, Inc. Sell -2.94% 21.63%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.54% 6.43%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.75% -1.83%
STAA STAAR Surgical Company Sell -3.57% 3.22%
The percentage of cash held in the portfolio is: 8.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
EW Sell All 5.06%
Assets Rebalanced
None
2023-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 6.81% 4.81%
THC Tenet Healthcare Corporation Buy 7.41% 18.12%
ISRG Intuitive Surgical, Inc. Buy 7.1% 9.86%
A Agilent Technologies, Inc. Buy 6.89% 8.31%
NEOG Neogen Corporation Buy 7.78% 4.6%
RMD ResMed Inc. Buy 6.67% -0.77%
LLY Eli Lilly and Company Buy 6.85% -0.58%
BMRN BioMarin Pharmaceutical Inc. Buy 6.85% 2.37%
CBAY CymaBay Therapeutics, Inc. Buy 6.85% 8.83%
SENS Senseonics Holdings, Inc. Buy 6.62% 5.95%
SGRY Surgery Partners, Inc. Buy 7.07% 6.83%
AMEH Apollo Medical Holdings, Inc. Buy 6.99% 2.96%
VKTX Viking Therapeutics, Inc. Buy 6.97% 0.9%
KIDS OrthoPediatrics Corp. Buy 6.91% 4.35%
QTRX Quanterix Corporation Buy 7.68% -0.93%
NVCR NovoCure Limited Buy 7.77% -3.36%
MRSN Mersana Therapeutics, Inc. Buy 7.21% 0.65%
AMN AMN Healthcare Services, Inc. Sell -3.79% 0.76%
MNKD MannKind Corporation Sell -3.97% -3.26%
NVAX Novavax, Inc. Sell -3.2% 16.84%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.77% 2.81%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.92% -3.66%
STAA STAAR Surgical Company Sell -3.78% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • STAA
Assets Removed
None
Assets Rebalanced
Asset Action Weight
QTRX Buy 0.21%
NEOG Buy 0.26%
NVCR Buy 0.43%
MRSN Buy 0.87%
2023-11-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 6.97% 5.7%
A Agilent Technologies, Inc. Buy 7.07% 9.3%
THC Tenet Healthcare Corporation Buy 6.87% 7.75%
ISRG Intuitive Surgical, Inc. Buy 7.18% 9.38%
NEOG Neogen Corporation Buy 6.85% 3.3%
RMD ResMed Inc. Buy 6.78% -0.8%
LLY Eli Lilly and Company Buy 6.93% -1.08%
BMRN BioMarin Pharmaceutical Inc. Buy 6.94% 2.01%
CBAY CymaBay Therapeutics, Inc. Buy 6.9% 7.82%
SENS Senseonics Holdings, Inc. Buy 6.82% 7.57%
KIDS OrthoPediatrics Corp. Buy 6.97% 3.68%
SGRY Surgery Partners, Inc. Buy 6.86% 2.02%
AMEH Apollo Medical Holdings, Inc. Buy 7.05% 2.26%
NVCR NovoCure Limited Buy 6.46% -7.58%
VKTX Viking Therapeutics, Inc. Buy 6.61% -5.73%
QTRX Quanterix Corporation Buy 6.81% -3.35%
MRSN Mersana Therapeutics, Inc. Buy 6.4% 0%
AMN AMN Healthcare Services, Inc. Sell -3.81% 1.91%
NVAX Novavax, Inc. Sell -3.31% 15.38%
MNKD MannKind Corporation Sell -3.82% 2.17%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.7% 6.09%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.84% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMRX
  • MRSN
Assets Removed
Asset Action Perf %
QDEL Buy All -6.44%
AMRX Sell All 3.8%
Assets Rebalanced
None
2023-11-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 6.89% 4.98%
A Agilent Technologies, Inc. Buy 6.99% 8.74%
THC Tenet Healthcare Corporation Buy 6.89% 8.69%
ISRG Intuitive Surgical, Inc. Buy 6.89% 5.52%
NEOG Neogen Corporation Buy 6.89% 4.53%
RMD ResMed Inc. Buy 6.89% 1.37%
LLY Eli Lilly and Company Buy 6.89% -1.12%
AMRX Amneal Pharmaceuticals, Inc. Buy 6.89% 6.65%
BMRN BioMarin Pharmaceutical Inc. Buy 6.89% 1.84%
CBAY CymaBay Therapeutics, Inc. Buy 6.78% 6.7%
SENS Senseonics Holdings, Inc. Buy 6.89% 9.19%
KIDS OrthoPediatrics Corp. Buy 6.89% 2.99%
SGRY Surgery Partners, Inc. Buy 6.89% 2.98%
AMEH Apollo Medical Holdings, Inc. Buy 6.89% 0.41%
NVCR NovoCure Limited Buy 6.89% -0.94%
VKTX Viking Therapeutics, Inc. Buy 6.89% -1.25%
QTRX Quanterix Corporation Buy 6.89% -1.72%
AMN AMN Healthcare Services, Inc. Sell -3.79% 1.61%
NVAX Novavax, Inc. Sell -3.5% 10.01%
MNKD MannKind Corporation Sell -3.96% -1.9%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.76% 3.96%
QDEL QuidelOrtho Corporation Sell -4.03% -3.04%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
ZBH Buy All -5.38%
Assets Rebalanced
Asset Action Weight
CBAY Sell -0.82%
EW Sell -0.73%
SENS Sell -0.89%
LLY Sell -2.32%
AMRX Sell -3.04%
BMRN Sell -7.64%
KIDS Buy 0.88%
SGRY Buy 0.88%
AMEH Buy 1.03%
NVCR Buy 1.11%
VKTX Buy 1.13%
THC Buy 1.14%
QTRX Buy 1.15%
ISRG Buy 1.31%
NEOG Buy 1.36%
RMD Buy 1.53%
2023-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 7.55% 3.07%
A Agilent Technologies, Inc. Buy 6.93% 6.83%
NEOG Neogen Corporation Buy 5.49% 2.98%
RMD ResMed Inc. Buy 5.24% -1.86%
THC Tenet Healthcare Corporation Buy 5.78% 8.34%
ISRG Intuitive Surgical, Inc. Buy 5.6% 4.94%
AMRX Amneal Pharmaceuticals, Inc. Buy 10.2% 8.55%
LLY Eli Lilly and Company Buy 9.64% 2.63%
BMRN BioMarin Pharmaceutical Inc. Buy 14.29% -0.74%
CBAY CymaBay Therapeutics, Inc. Buy 7.33% 1.96%
SENS Senseonics Holdings, Inc. Buy 7.49% 4.22%
NVCR NovoCure Limited Buy 5.89% 0%
SGRY Surgery Partners, Inc. Buy 5.89% 0%
AMEH Apollo Medical Holdings, Inc. Buy 5.89% 0%
KIDS OrthoPediatrics Corp. Buy 5.89% 0%
QTRX Quanterix Corporation Buy 5.89% 0%
VKTX Viking Therapeutics, Inc. Buy 5.89% 0%
AMN AMN Healthcare Services, Inc. Sell -3.67% 5.76%
MNKD MannKind Corporation Sell -3.97% -1.09%
NVAX Novavax, Inc. Sell -3.55% 9.43%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.9% 1.28%
QDEL QuidelOrtho Corporation Sell -3.92% 0.86%
ZBH Zimmer Biomet Holdings, Inc. Sell -3.86% -3.06%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
  • SGRY
  • AMEH
  • KIDS
  • QTRX
  • VKTX
Assets Removed
Asset Action Perf %
GKOS Buy All -5.96%
IRMD Buy All -6.67%
Assets Rebalanced
None
2023-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 7.54% 1.21%
A Agilent Technologies, Inc. Buy 6.78% 2.86%
NEOG Neogen Corporation Buy 5.15% -5.12%
RMD ResMed Inc. Buy 5.17% -4.78%
THC Tenet Healthcare Corporation Buy 5.52% 1.69%
ISRG Intuitive Surgical, Inc. Buy 5.51% 1.65%
AMRX Amneal Pharmaceuticals, Inc. Buy 9.71% 1.66%
LLY Eli Lilly and Company Buy 9.83% 2.94%
BMRN BioMarin Pharmaceutical Inc. Buy 14.28% -2.46%
CBAY CymaBay Therapeutics, Inc. Buy 7.31% 0%
SENS Senseonics Holdings, Inc. Buy 7.31% 0%
AMN AMN Healthcare Services, Inc. Sell -3.43% 13.37%
MNKD MannKind Corporation Sell -3.84% 3.8%
NVAX Novavax, Inc. Sell -3.63% 9%
GKOS Glaukos Corporation Sell -4.1% -1.91%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.84% 4.6%
QDEL QuidelOrtho Corporation Sell -3.81% 5.19%
ZBH Zimmer Biomet Holdings, Inc. Sell -3.84% -0.92%
IRMD IRadimed Corporation Sell -3.92% -2.94%
The percentage of cash held in the portfolio is: 46.28%
New Assets Added
  • CBAY
  • SENS
Assets Removed
None
Assets Rebalanced
None
2023-11-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 7.6% 1.28%
A Agilent Technologies, Inc. Buy 6.85% 3.13%
NEOG Neogen Corporation Buy 5.35% -2.2%
RMD ResMed Inc. Buy 5.22% -4.45%
THC Tenet Healthcare Corporation Buy 5.33% -2.41%
ISRG Intuitive Surgical, Inc. Buy 5.36% -1.98%
AMRX Amneal Pharmaceuticals, Inc. Buy 9.49% -1.43%
LLY Eli Lilly and Company Buy 9.56% -0.65%
BMRN BioMarin Pharmaceutical Inc. Buy 14.44% -2.07%
AMN AMN Healthcare Services, Inc. Sell -3.6% 9.8%
MNKD MannKind Corporation Sell -3.79% 5.71%
NVAX Novavax, Inc. Sell -3.91% 2.61%
GKOS Glaukos Corporation Sell -4.06% -0.18%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.79% 6.34%
QDEL QuidelOrtho Corporation Sell -3.82% 5.58%
ZBH Zimmer Biomet Holdings, Inc. Sell -3.81% 0.71%
IRMD IRadimed Corporation Sell -3.79% 1.06%
The percentage of cash held in the portfolio is: 61.37%
New Assets Added
None
Assets Removed
Asset Action Perf %
EDIT Sell All 14.06%
INGN Sell All -6.24%
OMI Sell All 13.67%
SGRY Sell All 7.24%
VNDA Sell All -22.65%
ARDX Sell All -11.22%
Assets Rebalanced
None
2023-11-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 7.45% 3.78%
EDIT Editas Medicine, Inc. Buy 8.74% 21.74%
VNDA Vanda Pharmaceuticals Inc. Buy 7.12% -0.92%
OMI Owens & Minor, Inc. Buy 6.23% 19.15%
A Agilent Technologies, Inc. Buy 6.66% 4.71%
SGRY Surgery Partners, Inc. Buy 6.95% 14.61%
INGN Inogen, Inc. Buy 5.31% 1.56%
NEOG Neogen Corporation Buy 5.25% 0.45%
RMD ResMed Inc. Buy 5.18% -0.88%
THC Tenet Healthcare Corporation Buy 5.29% 1.22%
ARDX Ardelyx, Inc. Buy 5.01% -4.24%
ISRG Intuitive Surgical, Inc. Buy 5.23% 0.01%
AMRX Amneal Pharmaceuticals, Inc. Buy 8.88% -3.56%
LLY Eli Lilly and Company Buy 9.58% 4.02%
BMRN BioMarin Pharmaceutical Inc. Buy 14.12% 0.02%
AMN AMN Healthcare Services, Inc. Sell -3.44% 9.93%
MNKD MannKind Corporation Sell -3.82% 0.82%
NVAX Novavax, Inc. Sell -3.8% 1.31%
GKOS Glaukos Corporation Sell -3.99% -3.02%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.82% 1.32%
QDEL QuidelOrtho Corporation Sell -3.79% 2.13%
ZBH Zimmer Biomet Holdings, Inc. Sell -3.67% 0%
IRMD IRadimed Corporation Sell -3.67% 0%
The percentage of cash held in the portfolio is: 22.98%
New Assets Added
  • ZBH
  • IRMD
Assets Removed
Asset Action Perf %
BCRX Sell All -4.54%
SMMT Sell All -6.41%
Assets Rebalanced
None
2023-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 7.27% 4.23%
BCRX BioCryst Pharmaceuticals, Inc. Buy 7.39% 5.93%
EDIT Editas Medicine, Inc. Buy 9.06% 29.86%
SMMT Summit Therapeutics Inc. Buy 6.85% -1.79%
VNDA Vanda Pharmaceuticals Inc. Buy 7.07% 1.37%
OMI Owens & Minor, Inc. Buy 6.47% 27.27%
A Agilent Technologies, Inc. Buy 6.54% 5.81%
SGRY Surgery Partners, Inc. Buy 6.97% 18.38%
INGN Inogen, Inc. Buy 5.22% 2.73%
NEOG Neogen Corporation Buy 5.17% 1.75%
RMD ResMed Inc. Buy 5.09% 0.11%
THC Tenet Healthcare Corporation Buy 5.24% 3.04%
ARDX Ardelyx, Inc. Buy 5.16% 1.5%
ISRG Intuitive Surgical, Inc. Buy 5.1% 0.29%
AMRX Amneal Pharmaceuticals, Inc. Buy 9.16% 2.38%
LLY Eli Lilly and Company Buy 9.02% 0.8%
BMRN BioMarin Pharmaceutical Inc. Buy 13.71% 0%
AMN AMN Healthcare Services, Inc. Sell -3.47% 6.31%
MNKD MannKind Corporation Sell -3.86% -3.26%
NVAX Novavax, Inc. Sell -3.84% -2.9%
GKOS Glaukos Corporation Sell -3.76% 0%
ACAD ACADIA Pharmaceuticals Inc. Sell -3.76% 0%
QDEL QuidelOrtho Corporation Sell -3.76% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • GKOS
  • ACAD
  • QDEL
  • BMRN
Assets Removed
Asset Action Perf %
VEEV Buy All 6.65%
MRSN Sell All 4.69%
Assets Rebalanced
None
2023-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 7.41% 5.12%
BCRX BioCryst Pharmaceuticals, Inc. Buy 7.29% 3.49%
EDIT Editas Medicine, Inc. Buy 8.48% 20.43%
SMMT Summit Therapeutics Inc. Buy 7.88% 11.79%
VNDA Vanda Pharmaceuticals Inc. Buy 7.19% 2.06%
OMI Owens & Minor, Inc. Buy 6.41% 24.95%
MRSN Mersana Therapeutics, Inc. Buy 6.37% 8.59%
A Agilent Technologies, Inc. Buy 6.42% 2.93%
SGRY Surgery Partners, Inc. Buy 6.18% 3.85%
INGN Inogen, Inc. Buy 5.28% 2.92%
NEOG Neogen Corporation Buy 5.26% 2.46%
RMD ResMed Inc. Buy 5.26% 2.52%
THC Tenet Healthcare Corporation Buy 5.19% 1.2%
ARDX Ardelyx, Inc. Buy 5.12% -0.25%
ISRG Intuitive Surgical, Inc. Buy 5.12% -0.23%
AMRX Amneal Pharmaceuticals, Inc. Buy 9.03% 0%
LLY Eli Lilly and Company Buy 9.03% 0%
VEEV Veeva Systems Inc. Sell -3.72% 5.67%
AMN AMN Healthcare Services, Inc. Sell -3.64% 2.68%
MNKD MannKind Corporation Sell -3.77% 0%
NVAX Novavax, Inc. Sell -3.77% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MNKD
  • NVAX
  • AMRX
  • LLY
Assets Removed
Asset Action Perf %
CLDX Buy All -19.21%
DNLI Sell All 5.92%
PODD Sell All 16.93%
Assets Rebalanced
None
2023-11-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 9.13% 19.62%
EW Edwards Lifesciences Corporation Buy 7.32% 5.08%
BCRX BioCryst Pharmaceuticals, Inc. Buy 7.35% 5.41%
EDIT Editas Medicine, Inc. Buy 8.4% 20.43%
SMMT Summit Therapeutics Inc. Buy 7.19% 3.08%
VNDA Vanda Pharmaceuticals Inc. Buy 7.21% 3.43%
OMI Owens & Minor, Inc. Buy 6.45% 27.08%
DNLI Denali Therapeutics Inc. Buy 6.44% 11.43%
MRSN Mersana Therapeutics, Inc. Buy 6.44% 10.94%
A Agilent Technologies, Inc. Buy 6.44% 4.36%
SGRY Surgery Partners, Inc. Buy 6.13% 4.19%
INGN Inogen, Inc. Buy 5.27% 3.9%
NEOG Neogen Corporation Buy 5.2% 2.46%
RMD ResMed Inc. Buy 5.17% 1.81%
THC Tenet Healthcare Corporation Buy 5.17% 1.78%
ARDX Ardelyx, Inc. Buy 5.09% 0.25%
ISRG Intuitive Surgical, Inc. Buy 5.09% 0.23%
VEEV Veeva Systems Inc. Sell -3.65% 6.42%
CLDX Celldex Therapeutics, Inc. Sell -4.12% -5.52%
AMN AMN Healthcare Services, Inc. Sell -3.7% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMN
Assets Removed
None
Assets Rebalanced
Asset Action Weight
DNLI Buy 0.78%
MRSN Buy 0.81%
A Buy 1.14%
SGRY Buy 0.84%
2023-11-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 8.42% 3.33%
EW Edwards Lifesciences Corporation Buy 7.64% 2.66%
BCRX BioCryst Pharmaceuticals, Inc. Buy 7.33% -1.57%
EDIT Editas Medicine, Inc. Buy 7.59% 1.88%
SMMT Summit Therapeutics Inc. Buy 7.64% 2.56%
VNDA Vanda Pharmaceuticals Inc. Buy 7.62% 2.29%
ISRG Intuitive Surgical, Inc. Buy 5.42% 0%
RMD ResMed Inc. Buy 5.42% 0%
THC Tenet Healthcare Corporation Buy 5.42% 0%
SGRY Surgery Partners, Inc. Buy 5.42% 0%
OMI Owens & Minor, Inc. Buy 5.42% 0%
INGN Inogen, Inc. Buy 5.42% 0%
ARDX Ardelyx, Inc. Buy 5.42% 0%
DNLI Denali Therapeutics Inc. Buy 5.42% 0%
MRSN Mersana Therapeutics, Inc. Buy 5.42% 0%
A Agilent Technologies, Inc. Buy 5.42% 0%
NEOG Neogen Corporation Buy 5.42% 0%
VEEV Veeva Systems Inc. Sell -3.81% 8.67%
CLDX Celldex Therapeutics, Inc. Sell -4.07% 2.48%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ISRG
  • RMD
  • THC
  • SGRY
  • OMI
  • INGN
  • ARDX
  • DNLI
  • MRSN
  • A
  • NEOG
Assets Removed
Asset Action Perf %
CYH Buy All 7.14%
ABUS Buy All 1.63%
ANAB Buy All 12.76%
PCRX Buy All 0.71%
ALPN Buy All -43.47%
Assets Rebalanced
None
2023-11-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 8.13% 1.33%
EW Edwards Lifesciences Corporation Buy 7.33% 0%
BCRX BioCryst Pharmaceuticals, Inc. Buy 7.33% 0%
EDIT Editas Medicine, Inc. Buy 7.33% 0%
SMMT Summit Therapeutics Inc. Buy 7.33% 0%
VNDA Vanda Pharmaceuticals Inc. Buy 7.33% 0%
ABUS Arbutus Biopharma Corporation Sell -4.16% 0%
ANAB AnaptysBio, Inc. Sell -3.71% 10.93%
PCRX Pacira BioSciences, Inc. Sell -4.01% 3.71%
ALPN Alpine Immune Sciences, Inc. Sell -4.29% -2.53%
VEEV Veeva Systems Inc. Sell -3.69% 10.05%
CLDX Celldex Therapeutics, Inc. Sell -3.93% 4.26%
CYH Community Health Systems, Inc. Sell -3.62% 17.86%
The percentage of cash held in the portfolio is: 82.62%
New Assets Added
  • EW
  • BCRX
  • EDIT
  • SMMT
  • VNDA
Assets Removed
Asset Action Perf %
MODV Sell All 21.73%
Assets Rebalanced
None
2023-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 7.98% 22.2%
PODD Insulet Corporation Buy 7.71% -3.79%
ABUS Arbutus Biopharma Corporation Sell -4.02% 3.26%
ANAB AnaptysBio, Inc. Sell -3.69% 11.2%
PCRX Pacira BioSciences, Inc. Sell -3.92% 5.51%
ALPN Alpine Immune Sciences, Inc. Sell -3.98% 4.68%
VEEV Veeva Systems Inc. Sell -3.75% 8.49%
CLDX Celldex Therapeutics, Inc. Sell -3.78% 7.8%
CYH Community Health Systems, Inc. Sell -3.67% 16.67%
The percentage of cash held in the portfolio is: 111.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
IRMD Buy All 1.13%
Assets Rebalanced
None
2023-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 7.65% 17.37%
PODD Insulet Corporation Buy 7.85% -1.82%
IRMD IRadimed Corporation Sell -4.14% -1.63%
ABUS Arbutus Biopharma Corporation Sell -3.9% 5.98%
ANAB AnaptysBio, Inc. Sell -3.65% 11.95%
PCRX Pacira BioSciences, Inc. Sell -3.89% 6.22%
ALPN Alpine Immune Sciences, Inc. Sell -3.78% 9.36%
VEEV Veeva Systems Inc. Sell -3.73% 8.86%
CLDX Celldex Therapeutics, Inc. Sell -3.76% 8.16%
CYH Community Health Systems, Inc. Sell -3.64% 17.06%
The percentage of cash held in the portfolio is: 114.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRTX Sell All -1.48%
CYTK Sell All 3.73%
Assets Rebalanced
None
2023-10-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 6.27% 0.18%
CYTK Cytokinetics, Incorporated Buy 6.63% 5.92%
MODV ModivCare Inc. Buy 7.49% 14.74%
PODD Insulet Corporation Buy 7.97% -0.57%
IRMD IRadimed Corporation Sell -3.99% 2.12%
ABUS Arbutus Biopharma Corporation Sell -3.97% 4.35%
ANAB AnaptysBio, Inc. Sell -3.8% 8.56%
PCRX Pacira BioSciences, Inc. Sell -3.86% 7.18%
ALPN Alpine Immune Sciences, Inc. Sell -3.47% 16.76%
VEEV Veeva Systems Inc. Sell -3.75% 8.56%
CLDX Celldex Therapeutics, Inc. Sell -3.88% 5.36%
CYH Community Health Systems, Inc. Sell -4.16% 5.56%
The percentage of cash held in the portfolio is: 102.52%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMRX Sell All -4.25%
FATE Sell All -13.37%
ESPR Sell All -22.34%
MYGN Sell All -8.91%
Assets Rebalanced
None
2023-10-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 6.23% 0.67%
CYTK Cytokinetics, Incorporated Buy 6.59% 6.5%
MODV ModivCare Inc. Buy 7.53% 16.64%
PODD Insulet Corporation Buy 8.14% 2.74%
FATE Fate Therapeutics, Inc. Buy 7.66% -10.89%
ESPR Esperion Therapeutics, Inc. Buy 6.95% -19.15%
AMRX Amneal Pharmaceuticals, Inc. Buy 7.88% -2%
MYGN Myriad Genetics, Inc. Buy 7.58% -5.83%
IRMD IRadimed Corporation Sell -3.88% 3.87%
ABUS Arbutus Biopharma Corporation Sell -3.86% 5.98%
ANAB AnaptysBio, Inc. Sell -3.9% 5.12%
PCRX Pacira BioSciences, Inc. Sell -3.81% 7.35%
ALPN Alpine Immune Sciences, Inc. Sell -3.53% 14.52%
VEEV Veeva Systems Inc. Sell -3.8% 6.33%
CLDX Celldex Therapeutics, Inc. Sell -3.87% 4.55%
CYH Community Health Systems, Inc. Sell -4.18% 3.97%
The percentage of cash held in the portfolio is: 72.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -22.92%
HAE Sell All -6.51%
STAA Sell All -11.44%
Assets Rebalanced
None
2023-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 6.1% 2.43%
CYTK Cytokinetics, Incorporated Buy 6.2% 4.12%
MODV ModivCare Inc. Buy 7.87% 26.62%
MRSN Mersana Therapeutics, Inc. Buy 6.76% -7.99%
PODD Insulet Corporation Buy 7.92% 3.75%
HAE Haemonetics Corporation Buy 8% -3.36%
STAA STAAR Surgical Company Buy 8.11% -2.08%
FATE Fate Therapeutics, Inc. Buy 7.95% -3.96%
ESPR Esperion Therapeutics, Inc. Buy 7.13% -13.83%
AMRX Amneal Pharmaceuticals, Inc. Buy 7.74% 0%
MYGN Myriad Genetics, Inc. Buy 7.74% 0%
IRMD IRadimed Corporation Sell -3.76% 3.16%
ABUS Arbutus Biopharma Corporation Sell -3.8% 3.8%
ANAB AnaptysBio, Inc. Sell -3.76% 4.95%
PCRX Pacira BioSciences, Inc. Sell -3.8% 4.01%
ALPN Alpine Immune Sciences, Inc. Sell -3.39% 14.72%
VEEV Veeva Systems Inc. Sell -3.7% 5.17%
CLDX Celldex Therapeutics, Inc. Sell -3.88% 0.69%
CYH Community Health Systems, Inc. Sell -4.26% -1.59%
The percentage of cash held in the portfolio is: 48.81%
New Assets Added
  • AMRX
  • MYGN
Assets Removed
None
Assets Rebalanced
None
2023-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 6.08% 1.95%
CYTK Cytokinetics, Incorporated Buy 6.21% 4.18%
MODV ModivCare Inc. Buy 7.43% 19.57%
MRSN Mersana Therapeutics, Inc. Buy 7.4% 0.69%
PODD Insulet Corporation Buy 8.25% 8.16%
HAE Haemonetics Corporation Buy 8.08% -2.4%
STAA STAAR Surgical Company Buy 7.86% -5.09%
FATE Fate Therapeutics, Inc. Buy 7.38% -10.89%
ESPR Esperion Therapeutics, Inc. Buy 7.01% -15.38%
IRMD IRadimed Corporation Sell -3.64% 6.11%
ABUS Arbutus Biopharma Corporation Sell -3.63% 8.15%
ANAB AnaptysBio, Inc. Sell -3.74% 5.44%
PCRX Pacira BioSciences, Inc. Sell -3.77% 4.73%
ALPN Alpine Immune Sciences, Inc. Sell -3.5% 11.89%
VEEV Veeva Systems Inc. Sell -3.66% 6.16%
CLDX Celldex Therapeutics, Inc. Sell -3.86% 1.22%
CYH Community Health Systems, Inc. Sell -4.19% 0%
The percentage of cash held in the portfolio is: 64.3%
New Assets Added
  • CYH
Assets Removed
Asset Action Perf %
WBA Buy All 3.6%
NVCR Sell All -9.98%
ENTA Sell All -9.78%
Assets Rebalanced
None
2023-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 5.9% 0.34%
CYTK Cytokinetics, Incorporated Buy 6.36% 8.2%
MODV ModivCare Inc. Buy 7.5% 22.4%
MRSN Mersana Therapeutics, Inc. Buy 7.65% 5.56%
PODD Insulet Corporation Buy 8.01% 6.49%
NVCR NovoCure Limited Buy 7.61% -6.85%
HAE Haemonetics Corporation Buy 8% -2.01%
STAA STAAR Surgical Company Buy 7.78% -4.71%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.57% -7.26%
FATE Fate Therapeutics, Inc. Buy 8.08% -0.99%
ESPR Esperion Therapeutics, Inc. Buy 7.12% -12.77%
IRMD IRadimed Corporation Sell -3.67% 4.09%
ABUS Arbutus Biopharma Corporation Sell -3.69% 5.43%
ANAB AnaptysBio, Inc. Sell -3.79% 2.8%
PCRX Pacira BioSciences, Inc. Sell -3.78% 3.03%
ALPN Alpine Immune Sciences, Inc. Sell -3.79% 3.31%
WBA Walgreens Boots Alliance, Inc. Sell -3.72% 6.67%
VEEV Veeva Systems Inc. Sell -3.71% 3.63%
CLDX Celldex Therapeutics, Inc. Sell -3.82% 0.77%
The percentage of cash held in the portfolio is: 48.39%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Sell All -9.35%
VCEL Sell All -6.95%
Assets Rebalanced
None
2023-10-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 5.88% 1.92%
CYTK Cytokinetics, Incorporated Buy 6.47% 12.09%
MODV ModivCare Inc. Buy 7.07% 17.46%
MRSN Mersana Therapeutics, Inc. Buy 7.29% 2.43%
PODD Insulet Corporation Buy 7.88% 6.59%
NVCR NovoCure Limited Buy 7.83% -2.43%
HAE Haemonetics Corporation Buy 8.01% -0.12%
STAA STAAR Surgical Company Buy 7.8% -2.72%
INGN Inogen, Inc. Buy 7.63% -4.88%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.8% -2.72%
VCEL Vericel Corporation Buy 7.76% -3.31%
FATE Fate Therapeutics, Inc. Buy 7.98% -0.5%
ESPR Esperion Therapeutics, Inc. Buy 7.6% -5.32%
IRMD IRadimed Corporation Sell -3.61% 3.9%
ABUS Arbutus Biopharma Corporation Sell -3.71% 3.26%
ANAB AnaptysBio, Inc. Sell -3.82% 0.38%
PCRX Pacira BioSciences, Inc. Sell -3.83% 0%
ALPN Alpine Immune Sciences, Inc. Sell -3.77% 2.05%
WBA Walgreens Boots Alliance, Inc. Sell -3.65% 6.72%
VEEV Veeva Systems Inc. Sell -3.75% 0.84%
CLDX Celldex Therapeutics, Inc. Sell -3.69% 2.52%
The percentage of cash held in the portfolio is: 32.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
VERU Sell All -6%
AGEN Sell All -10.53%
Assets Rebalanced
None
2023-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 5.84% 3.57%
CYTK Cytokinetics, Incorporated Buy 6.52% 15.62%
MODV ModivCare Inc. Buy 6.69% 13.63%
MRSN Mersana Therapeutics, Inc. Buy 7.34% 5.56%
PODD Insulet Corporation Buy 7.52% 4.02%
NVCR NovoCure Limited Buy 7.84% 0%
HAE Haemonetics Corporation Buy 7.84% 0%
STAA STAAR Surgical Company Buy 7.84% 0%
INGN Inogen, Inc. Buy 7.84% 0%
ENTA Enanta Pharmaceuticals, Inc. Buy 7.84% 0%
VCEL Vericel Corporation Buy 7.84% 0%
AGEN Agenus Inc. Buy 7.84% 0%
FATE Fate Therapeutics, Inc. Buy 7.84% 0%
ESPR Esperion Therapeutics, Inc. Buy 7.84% 0%
VERU Veru Inc. Buy 7.84% 0%
IRMD IRadimed Corporation Sell -3.56% 3.06%
ABUS Arbutus Biopharma Corporation Sell -3.85% -2.72%
ANAB AnaptysBio, Inc. Sell -3.82% -1.88%
PCRX Pacira BioSciences, Inc. Sell -3.8% -1.56%
ALPN Alpine Immune Sciences, Inc. Sell -3.74% 0.58%
WBA Walgreens Boots Alliance, Inc. Sell -3.84% -0.31%
VEEV Veeva Systems Inc. Sell -3.7% 0%
CLDX Celldex Therapeutics, Inc. Sell -3.7% 0%
The percentage of cash held in the portfolio is: 17.68%
New Assets Added
  • VEEV
  • CLDX
  • NVCR
  • HAE
  • STAA
  • INGN
  • ENTA
  • VCEL
  • AGEN
  • FATE
  • ESPR
  • VERU
Assets Removed
None
Assets Rebalanced
None
2023-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 5.85% 3.71%
CYTK Cytokinetics, Incorporated Buy 6.38% 13.24%
MODV ModivCare Inc. Buy 6.3% 7.11%
MRSN Mersana Therapeutics, Inc. Buy 8.01% 15.28%
PODD Insulet Corporation Buy 7.22% 0%
IRMD IRadimed Corporation Sell -3.52% 3.99%
ABUS Arbutus Biopharma Corporation Sell -3.84% -2.72%
ANAB AnaptysBio, Inc. Sell -3.73% 0.27%
PCRX Pacira BioSciences, Inc. Sell -3.77% -0.82%
ALPN Alpine Immune Sciences, Inc. Sell -3.66% 2.53%
WBA Walgreens Boots Alliance, Inc. Sell -3.82% 0%
The percentage of cash held in the portfolio is: 88.6%
New Assets Added
  • WBA
  • PODD
Assets Removed
Asset Action Perf %
VCEL Buy All -8.78%
Assets Rebalanced
None
2023-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 5.83% 2.88%
CYTK Cytokinetics, Incorporated Buy 6.33% 11.8%
MODV ModivCare Inc. Buy 6.2% 5%
MRSN Mersana Therapeutics, Inc. Buy 7.52% 7.64%
IRMD IRadimed Corporation Sell -3.47% 5.89%
VCEL Vericel Corporation Sell -3.85% -2.3%
ABUS Arbutus Biopharma Corporation Sell -3.8% -1.09%
ANAB AnaptysBio, Inc. Sell -3.82% -1.45%
PCRX Pacira BioSciences, Inc. Sell -3.73% 0.88%
ALPN Alpine Immune Sciences, Inc. Sell -3.78% 0%
The percentage of cash held in the portfolio is: 96.56%
New Assets Added
  • ALPN
Assets Removed
None
Assets Rebalanced
None
2023-10-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 5.84% 2.05%
CYTK Cytokinetics, Incorporated Buy 6.24% 9.12%
MODV ModivCare Inc. Buy 5.82% -2.43%
MRSN Mersana Therapeutics, Inc. Buy 7.05% 0%
IRMD IRadimed Corporation Sell -3.43% 8.01%
VCEL Vericel Corporation Sell -3.8% 0%
ABUS Arbutus Biopharma Corporation Sell -3.8% 0%
ANAB AnaptysBio, Inc. Sell -3.8% 0%
PCRX Pacira BioSciences, Inc. Sell -3.8% 0%
The percentage of cash held in the portfolio is: 93.66%
New Assets Added
  • VCEL
  • ABUS
  • ANAB
  • PCRX
  • MRSN
Assets Removed
None
Assets Rebalanced
None
2023-10-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 5.77% 1.28%
CYTK Cytokinetics, Incorporated Buy 6.69% 17.48%
MODV ModivCare Inc. Buy 5.94% 0%
IRMD IRadimed Corporation Sell -3.57% 3.77%
The percentage of cash held in the portfolio is: 85.17%
New Assets Added
  • MODV
Assets Removed
None
Assets Rebalanced
None
2023-10-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 5.67% -1.5%
CYTK Cytokinetics, Incorporated Buy 5.96% 3.59%
IRMD IRadimed Corporation Sell -3.75% 0%
The percentage of cash held in the portfolio is: 92.11%
New Assets Added
  • IRMD
Assets Removed
None
Assets Rebalanced
None
2023-10-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 5.76% 0%
CYTK Cytokinetics, Incorporated Buy 5.76% 0%
The percentage of cash held in the portfolio is: 88.47%
New Assets Added
  • VRTX
  • CYTK
Assets Removed
None
Assets Rebalanced
None
2023-10-06 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
SUPN Buy All 6.56%
Assets Rebalanced
None
2023-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
SUPN Supernus Pharmaceuticals, Inc. Sell -3.31% 7.38%
The percentage of cash held in the portfolio is: 103.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
DHR Sell All -15.68%
Assets Rebalanced
None
2023-10-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
DHR Danaher Corporation Buy 8.51% -2.12%
SUPN Supernus Pharmaceuticals, Inc. Sell -3.33% 5.84%
The percentage of cash held in the portfolio is: 94.83%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All 12.83%
Assets Rebalanced
None
2023-09-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
DHR Danaher Corporation Buy 8.49% -2.48%
CDMO Avid Bioservices, Inc. Sell -3.79% 10.25%
SUPN Supernus Pharmaceuticals, Inc. Sell -3.4% 4.1%
The percentage of cash held in the portfolio is: 98.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
CBAY Buy All 5.75%
AGEN Buy All 11.11%
VCYT Buy All 9.55%
CNC Sell All 4.24%
Assets Rebalanced
None
2023-09-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
CNC Centene Corporation Buy 8.78% 4.97%
DHR Danaher Corporation Buy 8.52% -2.38%
AGEN Agenus Inc. Sell -3.73% 7.14%
VCYT Veracyte, Inc. Sell -3.62% 9.75%
CDMO Avid Bioservices, Inc. Sell -3.98% 5.82%
SUPN Supernus Pharmaceuticals, Inc. Sell -3.47% 2.39%
CBAY CymaBay Therapeutics, Inc. Sell -3.91% 8.78%
The percentage of cash held in the portfolio is: 101.41%
New Assets Added
None
Assets Removed
Asset Action Perf %
BIO Buy All 4.73%
HQY Sell All 9%
Assets Rebalanced
None
2023-09-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 8.44% 6.71%
CNC Centene Corporation Buy 8.81% 5.34%
DHR Danaher Corporation Buy 8.51% -2.46%
BIO Bio-Rad Laboratories, Inc. Sell -3.8% 5.33%
AGEN Agenus Inc. Sell -3.66% 8.73%
VCYT Veracyte, Inc. Sell -3.58% 10.86%
CDMO Avid Bioservices, Inc. Sell -3.9% 7.57%
SUPN Supernus Pharmaceuticals, Inc. Sell -3.54% 0.24%
CBAY CymaBay Therapeutics, Inc. Sell -3.85% 10.23%
The percentage of cash held in the portfolio is: 96.58%
New Assets Added
None
Assets Removed
Asset Action Perf %
AORT Buy All -0.45%
IBRX Sell All -18.33%
Assets Rebalanced
None
2023-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 8.3% 6.26%
CNC Centene Corporation Buy 8.78% 6.22%
DHR Danaher Corporation Buy 8.57% -0.57%
IBRX ImmunityBio, Inc. Buy 6.57% -10.56%
AORT Artivion, Inc. Sell -3.91% 1.68%
BIO Bio-Rad Laboratories, Inc. Sell -3.78% 4.54%
AGEN Agenus Inc. Sell -3.59% 9.52%
VCYT Veracyte, Inc. Sell -3.52% 11.29%
CDMO Avid Bioservices, Inc. Sell -3.73% 10.62%
SUPN Supernus Pharmaceuticals, Inc. Sell -3.42% 2.46%
CBAY CymaBay Therapeutics, Inc. Sell -3.67% 13.32%
The percentage of cash held in the portfolio is: 93.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDXS Sell All -14.77%
Assets Rebalanced
None
2023-09-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 8.12% 4.1%
CNC Centene Corporation Buy 8.63% 4.67%
CDXS Codexis, Inc. Buy 7.91% -8.52%
DHR Danaher Corporation Buy 8.47% -1.52%
IBRX ImmunityBio, Inc. Buy 6.65% -9.17%
AORT Artivion, Inc. Sell -3.87% 2.65%
BIO Bio-Rad Laboratories, Inc. Sell -3.82% 3.43%
AGEN Agenus Inc. Sell -3.74% 5.56%
VCYT Veracyte, Inc. Sell -3.53% 10.78%
CDMO Avid Bioservices, Inc. Sell -3.65% 12.28%
SUPN Supernus Pharmaceuticals, Inc. Sell -3.3% 5.64%
CBAY CymaBay Therapeutics, Inc. Sell -3.74% 11.62%
The percentage of cash held in the portfolio is: 85.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Buy All 9.71%
IOVA Sell All -15.01%
Assets Rebalanced
None
2023-09-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 7.93% 2.34%
CNC Centene Corporation Buy 8.4% 2.47%
CDXS Codexis, Inc. Buy 8.31% -3.41%
DHR Danaher Corporation Buy 8.59% 0.39%
IBRX ImmunityBio, Inc. Buy 6.78% -6.94%
IOVA Iovance Biotherapeutics, Inc. Buy 6.59% -11.47%
PDSB PDS Biotechnology Corporation Sell -3.57% 10.05%
AORT Artivion, Inc. Sell -3.82% 3.3%
BIO Bio-Rad Laboratories, Inc. Sell -3.88% 1.5%
AGEN Agenus Inc. Sell -3.75% 4.76%
VCYT Veracyte, Inc. Sell -3.62% 7.9%
CDMO Avid Bioservices, Inc. Sell -3.6% 13.2%
SUPN Supernus Pharmaceuticals, Inc. Sell -3.29% 5.53%
CBAY CymaBay Therapeutics, Inc. Sell -3.73% 11.38%
The percentage of cash held in the portfolio is: 82.65%
New Assets Added
None
Assets Removed
Asset Action Perf %
IMGN Sell All -8.1%
BHVN Sell All -12.29%
ICPT Sell All -8.77%
Assets Rebalanced
None
2023-09-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
IMGN ImmunoGen, Inc. Buy 5.99% -1.63%
HQY HealthEquity, Inc. Buy 7.83% 2.31%
CNC Centene Corporation Buy 8.27% 2.12%
BHVN Biohaven Ltd. Buy 7.53% -7.1%
CDXS Codexis, Inc. Buy 8.45% -0.57%
ICPT Intercept Pharmaceuticals, Inc. Buy 7.94% -6.75%
DHR Danaher Corporation Buy 8.51% 0.69%
IBRX ImmunityBio, Inc. Buy 7.16% -0.56%
IOVA Iovance Biotherapeutics, Inc. Buy 6.73% -8.43%
PDSB PDS Biotechnology Corporation Sell -3.57% 9.03%
AORT Artivion, Inc. Sell -3.81% 2.33%
BIO Bio-Rad Laboratories, Inc. Sell -3.79% 2.6%
AGEN Agenus Inc. Sell -3.83% 1.59%
VCYT Veracyte, Inc. Sell -3.7% 4.82%
CDMO Avid Bioservices, Inc. Sell -3.66% 10.53%
SUPN Supernus Pharmaceuticals, Inc. Sell -3.34% 2.87%
CBAY CymaBay Therapeutics, Inc. Sell -3.87% 6.72%
The percentage of cash held in the portfolio is: 61.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMEH Sell All -4.94%
STAA Sell All -7.33%
EGRX Sell All -9.86%
Assets Rebalanced
None
2023-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
IMGN ImmunoGen, Inc. Buy 5.98% -1.38%
HQY HealthEquity, Inc. Buy 7.46% -2.22%
CNC Centene Corporation Buy 8.24% 2.14%
BHVN Biohaven Ltd. Buy 7.58% -6.02%
STAA STAAR Surgical Company Buy 7.96% -5.83%
CDXS Codexis, Inc. Buy 8.7% 2.84%
ICPT Intercept Pharmaceuticals, Inc. Buy 8.1% -4.47%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.89% -6.92%
DHR Danaher Corporation Buy 8.42% 0.11%
AMEH Apollo Medical Holdings, Inc. Buy 6.98% -2.58%
IBRX ImmunityBio, Inc. Buy 6.65% -7.22%
IOVA Iovance Biotherapeutics, Inc. Buy 7.32% 0%
PDSB PDS Biotechnology Corporation Sell -3.59% 8.01%
AORT Artivion, Inc. Sell -3.83% 1.42%
BIO Bio-Rad Laboratories, Inc. Sell -3.85% 0.61%
AGEN Agenus Inc. Sell -3.84% 0.79%
VCYT Veracyte, Inc. Sell -3.72% 3.95%
CDMO Avid Bioservices, Inc. Sell -3.75% 7.85%
SUPN Supernus Pharmaceuticals, Inc. Sell -3.31% 3.31%
CBAY CymaBay Therapeutics, Inc. Sell -3.99% 3.45%
The percentage of cash held in the portfolio is: 38.62%
New Assets Added
  • IOVA
Assets Removed
Asset Action Perf %
DVAX Sell All -3.96%
Assets Rebalanced
None
2023-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IMGN ImmunoGen, Inc. Buy 5.88% -1.32%
HQY HealthEquity, Inc. Buy 7.46% -0.46%
CNC Centene Corporation Buy 8.09% 2.06%
BHVN Biohaven Ltd. Buy 7.78% -1.8%
STAA STAAR Surgical Company Buy 8.08% -2.8%
CDXS Codexis, Inc. Buy 9.16% 10.23%
ICPT Intercept Pharmaceuticals, Inc. Buy 8.04% -3.46%
EGRX Eagle Pharmaceuticals, Inc. Buy 7.92% -4.87%
DVAX Dynavax Technologies Corporation Buy 7.99% -3.4%
DHR Danaher Corporation Buy 8.32% 0.7%
AMEH Apollo Medical Holdings, Inc. Buy 7.04% 0%
IBRX ImmunityBio, Inc. Buy 7.04% 0%
PDSB PDS Biotechnology Corporation Sell -3.49% 9.03%
AORT Artivion, Inc. Sell -3.66% 4.2%
BIO Bio-Rad Laboratories, Inc. Sell -3.87% -1.69%
AGEN Agenus Inc. Sell -3.95% -3.97%
VCYT Veracyte, Inc. Sell -3.76% 1.11%
CDMO Avid Bioservices, Inc. Sell -3.85% 3.88%
SUPN Supernus Pharmaceuticals, Inc. Sell -3.36% 0.17%
CBAY CymaBay Therapeutics, Inc. Sell -4.06% 0%
The percentage of cash held in the portfolio is: 37.2%
New Assets Added
  • CBAY
  • AMEH
  • IBRX
Assets Removed
Asset Action Perf %
AMRX Buy All -11.08%
ATXS Sell All -9.49%
VERU Sell All -9.09%
DXCM Sell All -6.84%
Assets Rebalanced
None
2023-09-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 5.59% -4.57%
IMGN ImmunoGen, Inc. Buy 5.8% -1.07%
VERU Veru Inc. Buy 5.38% -8.18%
DXCM DexCom, Inc. Buy 5.75% -1.81%
HQY HealthEquity, Inc. Buy 7.3% -1.08%
CNC Centene Corporation Buy 7.94% 1.76%
BHVN Biohaven Ltd. Buy 7.79% -0.21%
STAA STAAR Surgical Company Buy 7.86% -3.9%
CDXS Codexis, Inc. Buy 9.76% 19.32%
ICPT Intercept Pharmaceuticals, Inc. Buy 8% -2.45%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.01% -2.23%
DVAX Dynavax Technologies Corporation Buy 8.14% 0%
DHR Danaher Corporation Buy 8.14% 0%
PDSB PDS Biotechnology Corporation Sell -3.61% 4.34%
AORT Artivion, Inc. Sell -3.75% 0.19%
BIO Bio-Rad Laboratories, Inc. Sell -3.78% -0.89%
AMRX Amneal Pharmaceuticals, Inc. Sell -4.11% -9.73%
AGEN Agenus Inc. Sell -3.86% -3.17%
VCYT Veracyte, Inc. Sell -3.73% 0.47%
CDMO Avid Bioservices, Inc. Sell -3.85% 2.22%
SUPN Supernus Pharmaceuticals, Inc. Sell -3.31% 0%
The percentage of cash held in the portfolio is: 34.55%
New Assets Added
  • SUPN
  • DVAX
  • DHR
Assets Removed
Asset Action Perf %
DHR Buy All 1.37%
Assets Rebalanced
None
2023-09-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 5.67% -1.71%
IMGN ImmunoGen, Inc. Buy 5.75% -0.31%
VERU Veru Inc. Buy 5.56% -3.64%
DXCM DexCom, Inc. Buy 5.87% 1.74%
HQY HealthEquity, Inc. Buy 7.35% 1.14%
CNC Centene Corporation Buy 7.9% 2.86%
BHVN Biohaven Ltd. Buy 7.51% -2.21%
STAA STAAR Surgical Company Buy 7.93% -1.55%
CDXS Codexis, Inc. Buy 9.66% 19.89%
ICPT Intercept Pharmaceuticals, Inc. Buy 7.95% -1.6%
EGRX Eagle Pharmaceuticals, Inc. Buy 8.07% 0%
PDSB PDS Biotechnology Corporation Sell -3.48% 6.47%
AORT Artivion, Inc. Sell -3.67% 0.9%
BIO Bio-Rad Laboratories, Inc. Sell -3.67% 0.38%
AMRX Amneal Pharmaceuticals, Inc. Sell -4.04% -9.46%
DHR Danaher Corporation Sell -3.62% 1.77%
AGEN Agenus Inc. Sell -3.8% -3.17%
VCYT Veracyte, Inc. Sell -3.69% -0.08%
CDMO Avid Bioservices, Inc. Sell -3.69% 4.8%
The percentage of cash held in the portfolio is: 50.43%
New Assets Added
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2023-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 5.72% -2.51%
IMGN ImmunoGen, Inc. Buy 5.69% -3.01%
VERU Veru Inc. Buy 5.44% -7.27%
DXCM DexCom, Inc. Buy 5.95% 1.39%
HQY HealthEquity, Inc. Buy 7.52% 1.8%
CNC Centene Corporation Buy 7.88% 0.87%
BHVN Biohaven Ltd. Buy 7.71% -1.23%
STAA STAAR Surgical Company Buy 8.24% 0.65%
CDXS Codexis, Inc. Buy 8.14% -0.57%
ICPT Intercept Pharmaceuticals, Inc. Buy 8.21% 0%
PDSB PDS Biotechnology Corporation Sell -3.6% 4.77%
AORT Artivion, Inc. Sell -3.72% 1.16%
BIO Bio-Rad Laboratories, Inc. Sell -3.67% 2.17%
AMRX Amneal Pharmaceuticals, Inc. Sell -4.05% -8.11%
DHR Danaher Corporation Sell -3.62% 3.37%
AGEN Agenus Inc. Sell -3.81% -1.59%
VCYT Veracyte, Inc. Sell -3.74% 0.12%
CDMO Avid Bioservices, Inc. Sell -3.77% 4.52%
The percentage of cash held in the portfolio is: 59.47%
New Assets Added
  • ICPT
Assets Removed
None
Assets Rebalanced
None
2023-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 5.77% -1.71%
IMGN ImmunoGen, Inc. Buy 5.78% -1.63%
VERU Veru Inc. Buy 5.6% -4.55%
DXCM DexCom, Inc. Buy 6.09% 3.74%
HQY HealthEquity, Inc. Buy 7.46% 0.99%
CNC Centene Corporation Buy 7.81% -0.03%
BHVN Biohaven Ltd. Buy 7.53% -3.7%
STAA STAAR Surgical Company Buy 8.2% 0%
CDXS Codexis, Inc. Buy 8.2% 0%
PDSB PDS Biotechnology Corporation Sell -3.8% -0.34%
AORT Artivion, Inc. Sell -3.83% -1.68%
BIO Bio-Rad Laboratories, Inc. Sell -3.68% 1.96%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.89% -3.78%
DHR Danaher Corporation Sell -3.65% 2.65%
AGEN Agenus Inc. Sell -3.63% 3.17%
VCYT Veracyte, Inc. Sell -3.74% 0.16%
CDMO Avid Bioservices, Inc. Sell -3.93% 0.37%
The percentage of cash held in the portfolio is: 67.72%
New Assets Added
  • STAA
  • CDXS
Assets Removed
None
Assets Rebalanced
None
2023-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 5.75% -2.51%
IMGN ImmunoGen, Inc. Buy 5.81% -1.44%
VERU Veru Inc. Buy 5.52% -6.36%
DXCM DexCom, Inc. Buy 5.95% 0.9%
HQY HealthEquity, Inc. Buy 7.28% -1.9%
CNC Centene Corporation Buy 7.73% -1.55%
BHVN Biohaven Ltd. Buy 7.48% -4.73%
PDSB PDS Biotechnology Corporation Sell -3.76% 1.02%
AORT Artivion, Inc. Sell -3.81% -0.65%
BIO Bio-Rad Laboratories, Inc. Sell -3.64% 3.26%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.84% -1.89%
DHR Danaher Corporation Sell -3.64% 3.36%
AGEN Agenus Inc. Sell -3.68% 2.38%
VCYT Veracyte, Inc. Sell -3.67% 2.57%
CDMO Avid Bioservices, Inc. Sell -3.97% 0%
The percentage of cash held in the portfolio is: 84.48%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2023-09-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 6.01% 2.63%
IMGN ImmunoGen, Inc. Buy 5.69% -2.76%
VERU Veru Inc. Buy 5.53% -5.45%
DXCM DexCom, Inc. Buy 5.94% 1.44%
HQY HealthEquity, Inc. Buy 7.58% 2.93%
CNC Centene Corporation Buy 7.79% 0%
BHVN Biohaven Ltd. Buy 7.79% 0%
PDSB PDS Biotechnology Corporation Sell -3.8% -0.85%
AORT Artivion, Inc. Sell -3.81% -1.62%
BIO Bio-Rad Laboratories, Inc. Sell -3.72% 0.57%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.74% 0%
DHR Danaher Corporation Sell -3.71% 0.81%
AGEN Agenus Inc. Sell -3.74% 0%
VCYT Veracyte, Inc. Sell -3.74% 0%
The percentage of cash held in the portfolio is: 79.92%
New Assets Added
  • AGEN
  • VCYT
  • CNC
  • BHVN
Assets Removed
Asset Action Perf %
ESPR Sell All -14.72%
Assets Rebalanced
None
2023-09-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 5.96% 1.94%
ESPR Esperion Therapeutics, Inc. Buy 5.17% -11.66%
IMGN ImmunoGen, Inc. Buy 5.72% -2.13%
VERU Veru Inc. Buy 5.58% -4.55%
DXCM DexCom, Inc. Buy 6.04% 3.35%
HQY HealthEquity, Inc. Buy 7.36% 0%
PDSB PDS Biotechnology Corporation Sell -3.74% 0.68%
AORT Artivion, Inc. Sell -3.85% -2.59%
BIO Bio-Rad Laboratories, Inc. Sell -3.74% 0%
AMRX Amneal Pharmaceuticals, Inc. Sell -3.74% 0%
DHR Danaher Corporation Sell -3.74% 0%
The percentage of cash held in the portfolio is: 82.95%
New Assets Added
  • BIO
  • AMRX
  • DHR
  • HQY
Assets Removed
None
Assets Rebalanced
None
2023-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 5.89% 0.69%
ESPR Esperion Therapeutics, Inc. Buy 5.28% -9.82%
IMGN ImmunoGen, Inc. Buy 5.68% -2.95%
VERU Veru Inc. Buy 5.8% -0.91%
DXCM DexCom, Inc. Buy 5.68% -2.99%
PDSB PDS Biotechnology Corporation Sell -3.74% 0.85%
AORT Artivion, Inc. Sell -3.75% 0%
The percentage of cash held in the portfolio is: 79.16%
New Assets Added
  • AORT
Assets Removed
Asset Action Perf %
IONS Sell All -3.72%
Assets Rebalanced
None
2023-09-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 5.92% 1.71%
IONS Ionis Pharmaceuticals, Inc. Buy 5.74% -1.44%
ESPR Esperion Therapeutics, Inc. Buy 5.71% -1.84%
IMGN ImmunoGen, Inc. Buy 5.79% -0.56%
VERU Veru Inc. Buy 5.5% -5.45%
DXCM DexCom, Inc. Buy 5.68% -2.36%
PDSB PDS Biotechnology Corporation Sell -3.75% 0%
The percentage of cash held in the portfolio is: 69.4%
New Assets Added
  • PDSB
Assets Removed
Asset Action Perf %
IRMD Sell All -6.89%
Assets Rebalanced
None
2023-08-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 5.92% 2.74%
IONS Ionis Pharmaceuticals, Inc. Buy 5.72% -0.71%
ESPR Esperion Therapeutics, Inc. Buy 5.66% -1.84%
IRMD IRadimed Corporation Buy 5.76% 0%
IMGN ImmunoGen, Inc. Buy 5.76% 0%
VERU Veru Inc. Buy 5.76% 0%
DXCM DexCom, Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 59.64%
New Assets Added
  • IRMD
  • IMGN
  • VERU
  • DXCM
Assets Removed
None
Assets Rebalanced
None
2023-08-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 5.79% 0.57%
IONS Ionis Pharmaceuticals, Inc. Buy 5.79% 0.49%
ESPR Esperion Therapeutics, Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 82.66%
New Assets Added
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2023-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 5.76% 0%
IONS Ionis Pharmaceuticals, Inc. Buy 5.76% 0%
The percentage of cash held in the portfolio is: 88.47%
New Assets Added
  • ATXS
  • IONS
Assets Removed
None
Assets Rebalanced
None
2023-08-22 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All 2.77%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings